Image acquisition for medical dose preparation system

Information

  • Patent Grant
  • 10971257
  • Patent Number
    10,971,257
  • Date Filed
    Friday, September 28, 2018
    6 years ago
  • Date Issued
    Tuesday, April 6, 2021
    3 years ago
Abstract
Use of improved image acquisition for a medical dose preparation system. The medical dose preparation system may include a work station for capturing medical dose preparation images (e.g., to document preparation of a mediation dose). The medical dose preparation image may be captured by a video data stream processor capable of performing an auto cropping technique on a video data stream received from an image device. Accordingly, memory resources may be more efficiently employed while maintaining high quality medical dose preparation images.
Description
BACKGROUND OF THE INVENTION

Many care providers have a pharmacy that prepares medical doses for administration to patients that are treated by the care provider. In this regard, the pharmacies may employ a formulary to prepare medications in order to fulfill medical dose orders that are ordered by care provider personnel (e.g., physicians) for administration to patients. Some medical doses to be prepared may include compounded sterile products (CSPs) that may be prepared in a specially constructed and controlled environment (e.g., an “IV Room”) in the pharmacy. The process of preparing medical doses may be carried out in accordance with local care provider policy, governmental regulations, industry organizations (e.g., Chapter <797> of the United States Pharmacopoeia), or other applicable policies. For example, the preparation of medications may generally occur in a laminar airflow hood, isolator, or biological safety cabinet, by an operator (typically a pharmacy technician) who is tasked with preparing the medical doses. Once the medical doses are prepared, the medical doses may be required to be verified by a pharmacist prior to being dispensed from the pharmacy for administration to a patient.


In traditional pharmacy management techniques, medical dose orders may be provided to a printer that prints labels indicative of the medical dose order that are to be applied to finished doses once the doses are prepared. A pharmacy technician may be required to retrieve labels from a label printer and use those labels as work order travelers in the process of preparing each dose. Once the dose is prepared, the technician may apply a label to the dose. The completed, labeled dose may be set aside for a pharmacist to check along with, for example, source ingredients, medication receptacles used in the course of preparing the dose, and/or other material. In this regard, in order to check a dose, the pharmacist may be required to enter the clean room in which the doses are prepared and physically observe the materials associated with the dose order. As such, the checking of prepared doses may require the pharmacist to dress in protective clothing or equipment, which takes time and resources.


Furthermore, the only prompt a pharmacy may receive to prepare a medical dose order is the printing of the label. In this regard, if a label becomes lost or damaged, a dose may not be prepared. Additionally, prioritizing work also becomes difficult because the label stack at the label printer may be the only evidence of what doses have been ordered, prepared, and/or dispensed. As such, relying on physical labels alone to track doses may result in unprepared, lost, or duplicate doses. In some cases, pharmacies may produce duplicate labels as a matter of course such that the pharmacy must review each label against the other, already received labels, to determine if a label represents a new dose order that needs to be prepared. This practice may lead to increased administrative overhead in the pharmacy that add operational costs and reduce pharmacy efficiency.


Furthermore, while instructions for preparation of a drug may be recorded in official FDA-approved literature for the drug, pharmacy technicians may not reliably consult the literature when preparing doses. Rather, pharmacy technicians may memorize the steps needed for the most common drugs, and then generalize those steps to other drugs to be prepared without verifying the protocols associated with a particular drug. In this regard, if the dose order includes special instructions that a pharmacy technician does not recognize, references regarding the proper techniques may not be present or may not be consulted. Accordingly, dose orders including special instructions often must be prepared by more experienced technicians or at the direction of more experienced technicians. In either regard, the protocol used to prepare the dose may not conform to the FDA-approved literature for the drug being prepared.


Further still, in traditional pharmacy management techniques, the pharmacy technician may be responsible for creating records that are maintained in relation to doses that have been prepared and products from the formulary that were employed to make the dose. For example, a pharmacy technician may be tasked with transcribing information such as lot numbers, expiration dates, serial numbers, or the like. The manual creation of records requires labor intensive practices that may result in pharmacy inefficiencies, introduces the potential for errors in the records, and may result in virtually unsearchable paper records.


SUMMARY OF THE INVENTION

In this regard, the present disclosure relates to embodiments of a medical dose preparation management system. The medical dose preparation management system may be capable of receiving dose orders, creating digital dose orders from the received dose orders, and managing the digital dose orders. For example, the medical dose preparation management system may be operable to create and store information related to the preparation of medical doses. Such information may be used to verify a medical dose order by a pharmacist, track a medical dose order in a pharmacy or care provider, be retained in connection with the digital dose order record for auditing, compliance, or quality assurance purposes, or otherwise be utilized in the management of the dose order before or after administration to a patient. In other words, the medical dose preparation management system may provide, in an automatic manner, an improved system that allows tracking a medical dose order in a pharmacy or care provider. The medical dose preparation management system may provide, in an automatic manner that the medical dose be retained in connection with the digital dose order record for auditing, compliance, or quality assurance purposes, or otherwise be utilized in the management of the dose order before or after administration to a patient. Hence, the medical dose preparation management system provides an improved man machine interaction, among others meeting the high level of compliance requirements in drug manufacturing and distribution with little or without any interference of a human personnel necessary. One example of information that may be created and stored in connection with a medical dose order is one or more medical dose preparation images. For example, a work station at which a dose order is prepared may include an imaging device (e.g., a digital camera) capable of capturing images related to the preparation of the medical dose. In an embodiment, the medical dose preparation images may include medication receptacles used in the preparation of the dose including, for example, a source receptacle, a transference receptacle, and/or an administration receptacle. Accordingly, the medical dose preparation images may be used to document or evidence the preparation of a medical dose order. Thus, the system provides an improved man machine interaction since less or even no interaction by a human person is necessary and still allows for accurate and trustworthy documentation.


Given the potential for capturing and storing a large number of medical dose preparation images, it may be advantageous to reduce the size in memory of medical dose preparation images. However, as such images may be used in a variety of contexts (e.g., including during verification of dose orders by a pharmacist), image quality is generally of great concern such that resolution is preferably not reduced when storing medical dose preparation images. In this regard, reduction in the physical size of an image (i.e., cropping the image to remove uninformative or useless portions of the image) may be used to effectively reduce the size of a medical dose preparation image in memory without reducing the resolution of the image.


However, manually cropping each medical dose preparation image may be burdensome and increase the cost and time required to prepare doses. In this regard, an apparatus described herein may employ an auto cropping operation to automatically reduce the size in memory of medical dose preparation images. For example, a region of interest in an image may be determined. The region of interest in an image may be captured as a medical dose preparation image that eliminates at least a portion of image data not within the region of interest.


Thus, the amount of image data stored in memory may be reduced without a reduction in resolution of the corresponding image and/or the resolution of a captured image may be increased while maintaining or reducing the amount of corresponding image data stored in memory. That is, for a given image resolution, the amount of corresponding image data may be reduced by reducing the size of the image. Thus, with little hardware resources, e.g., little memory capacity, a large amount of data can be stored. Moreover, with little hardware resources, e.g., little processing power, image data can be processed.


Additionally or alternatively, for a given amount of image data, a higher resolution image may be stored if the corresponding image data is only that of a cropped portion of the image. Accordingly, if the amount of image data is reduced, the computational overhead required to process, store, or otherwise take action with respect to the image may be reduced such that work flows at the work station may occur more quickly. Additionally or alternatively, if the resolution of an image is increased, a review of the image may be improved by allowing for capture of finer details (e.g., to allow for magnification of the image during a review by a pharmacist or the like).


In this regard, a first aspect described herein includes an apparatus for processing medical dose preparation image data in a system for medical dose preparation management. The system includes an imaging device (e.g., a digital camera) having an imaging field encompassing a medical dose preparation staging region. The imaging device is operable to output digital image data (e.g., corresponding to still digital images, a digital video data stream, and/or other forms of digital image data) of the imaging field including the medical dose preparation staging region. The system also includes a processor in operative communication with the imaging device to receive the digital image data of the imaging field. The system allows for automation of documenting medical dose order preparation and/or delivery. In particular the system may allow for such automation at a very high speed and/or increased image resolution which would otherwise not be possible by a human person. In other words, the system advantageously combines digital image processing with medical dose order preparation and/or drug delivery that would otherwise not have been done, since, according to this application, data processing may be carried at a high speed and/or with increased image resolution.


The system of the first aspect may include a display that is in operative communication with the processor to receive the digital image data of the imaging field and display a corresponding image that is perceivable by a user. The processor is operable to process the digital image data to identify at least one region of interest within the imaging field corresponding to at least one medication receptacle disposed in the medical dose preparation staging region. As such, in the event a display is utilized as described above, the region of interest may be visually differentiated on the display by the processor in a manner perceivable by the user. Hence, by the system, without the need of physically controlling the imaging device or accessing one or more medication receptacles at the medical dose preparation staging region, by a human person, it is possible to allow for the high level of documentation desired in medical dose preparation and/or delivering. In other words, the system allows relieving the human person from and/or assisting the user in the task of manual steps to obtain detailed documentation (e.g., detailed image data). Even more, since the documentation is machine aided or even completely carried out by the machine, namely the system described in this application, the documentation is more reliably or trustworthy as compared to the documentation by a human person. It may even only be possible to assure such documentation since the system strictly follows machine rules without deviation such as are possible for a human person.


The system of the first aspect may also include a user control device that is in operative communication with the processor to initiate the capture of a medical dose preparation image data from the digital image data. Other embodiments may include other mechanisms for initiating the capture of a medical dose preparation image. In any regard, the medical dose preparation image data may include image data corresponding to at least a portion of the region of interest and may exclude at least a portion of the imaging field (e.g., corresponding to a portion of the image data outside the region of interest). The system may also include a memory in operative communication with the processor to receive and store the medical dose preparation image data. The user control device provides for improved man machine interaction due to, e.g., in connection with the processor automatically processing the image.


A number of feature refinements and additional features are applicable to the first aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the following features that will be discussed may be, but are not required to be, used with any other feature or combination of features of the first aspect. In an embodiment, the processor may be operable to analyze the digital image data to identify the region of interest. For example, the processor may be operable to analyze a predetermined subset of the digital image data (e.g., a subset of the pixels of the digital image data) to identify the region of interest. The subset may correspond to a predetermined portion of the digital image data such that the analysis of the image data may be executed on a portion, but not the entirety of the digital image data.


In an application, the analysis may include comparing the digital image data to a background image of the medical dose preparation staging region. In this regard, the background image may not include any medication receptacle in the medical dose preparation staging region. That is, the background image may represent the appearance of the medical dose preparation staging region in the absence of any object (e.g., a medication receptacle or the like). Accordingly, the predetermined subset of the digital image data may be compared to a corresponding subset of the background image. For example, corresponding ones of the subset of pixels in the digital image data and the background image may be compared.


In an application, the plurality of pixels may extend across substantially the entire digital image data in at least a first direction (e.g., a width of the image data). Additionally, the plurality of pixels may extend across substantially all of the digital image data in a second direction perpendicular to the first direction (e.g., a height of the image data). As such, the plurality of pixels corresponding to the predetermined subset of the image data may form a grid over the digital image data. The grid may comprise grid lines that are spaced in relation to a known size of medication receptacles. For instance, the grid lines may be spaced such that at least two grid lines cross the medical receptacle in at least two dimensions (e.g., corresponding to both a width and a length of the receptacle) even for the smallest known medication receptacle to be imaged.


In an embodiment, the region of interest may be defined by a bounding area defined by a plurality of edges. Each of the plurality of edges may be disposed at an identified location of the predetermined subset of the digital image data (e.g., along at least a portion of a grid line) at least partially based on a threshold difference between the digital image data and the background image at the identified location. In one example, the processor may be operable to calculate intensity data for each pixel of the predetermined subset of the digital image data and for each pixel of the corresponding predetermined subset of the background image. The intensity data may be filtered (e.g., high pass and/or low pass filtering). The threshold difference may correspond to a predetermined difference in intensity data between the predetermined subset of the digital image data and the background image.


In various embodiments, the digital image data may include discrepancies relative to the background image that, rather than being attributable to the presence of a medication receptacle, are solely attributable to slight variations in positions of the background image relative to the background of the digital image data, lighting variations, or other minor discrepancies. In this regard, each pixel of the predetermined subset may be compared to a plurality of adjacent corresponding pixels from the background image. In this regard, insignificant variations related to the discrepancies disclosed above may be disregarded in the analysis.


In an application, the identified location resulting from the comparison of intensity data between the digital image data and the background image may correspond to one of a minimum and/or maximum threshold difference along the grid lines in a first direction and/or in a second direction. That is, two threshold differences may be identified in either or both of the first and second direction corresponding to the extents of the medication receptacle in the width and/or height dimension. In still another application, the identified location may be selected to correspond to the next most remote grid line of the grid exterior to the threshold difference in the first direction and in the second direction along the grid line. As such, if a portion of the medication receptacle extends beyond a grid line along which a threshold difference is identified, the full portion of the receptacle may still be contained in the region of interest if the identified location is selected as the next remote grid line. Summarizing the above, the system provides an improved man machine interaction, e.g., by relieving the user from and/or assisting the user in the manual and/or mental task to control the imaging device or manipulate one or more medication receptacles.


A second aspect described herein includes a method for processing and capturing medical dose preparation image data. The method includes encompassing a medical dose preparation staging region in an imaging field of an imaging device. The method further includes obtaining digital image data of the imaging field. The method also includes identifying, at a processor in operative communication with the imaging device, a region within the imaging field corresponding to at least one medication receptacle disposed in the medical dose preparation staging region. The method may also include displaying the digital image data on a display. The region of interest may be visibly distinguished by the processor on the display in a manner that is perceivable by a user.


The method of the second aspect may also include receiving an input from a user control device to initiate capture of medical dose preparation image data from the digital image data. The medical dose preparation image data includes image data corresponding to at least a portion of the region. The method further includes storing the medical dose preparation image data in a memory. In various method embodiments, the method may employ a system comprising any of the system features described herein.


According to yet another aspect, a computer program product is provided that can be stored on a computer readable medium and/or can be implemented as computer processable data stream, wherein the computer program product comprises computer processable instructions, which instructions when read in the memory of a computer and executed by the computer cause the computer to carry out the method(s) as described in general above, and in more specific examples below.


A number of feature refinements and additional features are applicable to the second aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the following features that will be discussed may be, but are not required to be, used with any other feature or combination of features of the second aspect.


For example, the speed at which the identifying operation occurs may be important to the method of the second aspect. As may be appreciated, the volume of dose orders prepared in a pharmacy or the like may be relatively large. As such, efficient preparation of the medical dose order may be of great importance. In this regard, it may be desirable to have any auto cropping operation occur relatively quickly so as to prevent preparation delays when preparing the medical dose order.


Accordingly, in an embodiment, the digital image data may comprise a video stream data. In this embodiment, the identifying may occur more rapidly than a refresh rate of the video data stream. As such, each successive frame of the video data stream may undergo the auto cropping operation without slowing the speed at which the video data stream is captured or displayed.


Numerous additional features and advantages of the present invention will become apparent to those skilled in the art upon consideration of the embodiment descriptions provided hereinbelow.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a schematic and flow chart depicting an embodiment of a medical dose preparation management system and an embodiment of the operation thereof.



FIG. 2 is a schematic view of an embodiment of a work station for use in a medical dose preparation management system.



FIG. 3 depicts an embodiment of a background image for use in an embodiment of an auto cropping operation.



FIG. 4 depicts an embodiment of a video data stream that may be the subject of an auto cropping operation.



FIG. 5 depicts the video data stream of FIG. 4 with a subset of the image identified.



FIG. 6 depicts the background image of FIG. 3 with a subset of the background image corresponding to the subset of FIG. 5 identified.



FIG. 7 depicts an embodiment of an image taken from a video data stream.



FIG. 8 is a plot depicting a mathematical transform of data obtained from the image of FIG. 7.



FIG. 9 is a plot depicting raw pixel intensity data obtained from the image of FIG. 7.



FIG. 10 is a plot depicting processed intensity data from the image of FIG. 7.



FIG. 11 depicts the video data stream of FIG. 4 with certain features applicable to the auto cropping operation highlighted.



FIG. 12 depicts a display output perceivable by a user corresponding to the video data stream of FIG. 4 once an auto cropping operation has been performed thereon.



FIGS. 13 and 14 are examples of medical dose preparation images obtained from the video data stream of FIG. 4 resulting from an auto cropping operation performed thereon.





DETAILED DESCRIPTION

While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that it is not intended to limit the invention to the particular form disclosed, but rather, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the claims.



FIG. 1 shows an embodiment of a system 10 that may be used at a care provider pharmacy 12 to assist in the preparation and/or management of medical doses. The system 10 may include a dose order input 20 to receive medical dose orders. The dose order input 20 may be utilized by care provider personnel (e.g., physicians, nurses, etc.) to order medical doses.


The medical dose orders received at the dose order input 20 may be specific to patients or may be orders that are not associated with a patient at the time of ordering. In this regard, the medical dose order may correspond to a contained medication unit that may comprise one of the following: a patient specific unit comprising a medication unit designated for administration to a specific patient; a non-patient specific unit comprising a medication unit to be subsequently designated for administration to a specific patient; or, a medication component source unit to be used in the preparation of a patient specific unit or a non-patient specific unit (e.g., that will be designated for administration to a specific patient after preparation).


Examples of contained medication units that may correspond to medication dose orders include: compounded sterile products; injectable medications; chemotherapy preparations; or nutritional supplements requiring administration by a patient care provider (e.g., sterile injectable nutritional supplements).


In the latter regard, nutritional supplements may include total parenteral nutrition (TPN) or components of TPN. Furthermore, nutritional supplements may include partial nutritional supplements. The nutritional supplements may include a pre-mix bag, base and additive components separately or in combination, or other forms of nutritional supplements or components thereof. The nutritional supplements may be for administration via intravenous injections, in an edible form, or for use with a feeding tube or the like.


In any regard, the medical dose may include one or more portions of information that may be used to assist in preparation of the mediation dose, may be associated with the administration of the dose order to a patient, or may otherwise relate to the dose order. For example, the dose order may include information corresponding to: a medication identity; a medication amount; a medication concentration;

    • information associated with a patient to whom the medication unit associated with the medication dose order is to be administered; scheduling information (e.g., an administration time) for the medication unit associated with medication dose order; or other appropriate information regarding the medication unit associated with the medication dose order.


In any regard, the medical dose orders may be communicated to a medical dose preparation management system 30. The medical dose preparation management system 30 may be operable to acquire 50 dose order data from the dose order information received from the order processor 20. The medical dose preparation management system 30 may also preprocess 52 dose order data. The preprocessing 52 may include, for example, generating a digital dose order record that is maintained by the medical dose preparation management system 30. The digital dose order record may be automatically populated with data that may be obtained from the order such as, for example, any of the information described above in connection with the medical dose order. In this regard, information may be parsed, scraped, or otherwise obtained from the medication dose order received at the order input 20. Specifically, in an embodiment, the medical dose preparation management system 30 may be operable to scrape data addressed to a human readable output (e.g., a printer) from the order input 20 to populate the medical dose order record with data corresponding to the medical dose order.


In an embodiment, the medical dose preparation management system 30 may be in operative communication with a medication dose order database 32. In this regard, the medication dose order database 32 may be located at the care provider facility (i.e., be onsite relative to the care provider hospital 12). The medical dose preparation management system 30 may additionally or alternatively be operable to communicate with a remote medication dose order database 34. In this regard, the medical dose preparation management system 30 may communicate with the remote medication dose order database 34 via a network or the like. In either regard, the medication dose order database 32 or 34 may be operable to store medication dose order records in the medication dose order database 32 and/or 34. In addition, the medication dose order database 32 or 34 may store dose order metadata in corresponding relation to respective ones of the stored medication dose orders. The medication dose order database 32 or 34 may store active dose orders (e.g., corresponding to dose orders that have been generated but not yet administered to the patient) or archived dose orders (e.g., corresponding to dose orders that have been administered to a patient). Redundant data may be stored at the on-site medical dose order database 32 and the off-site medical dose order database 34. For example, the off-site medical dose order database 34 may be a backup version of the on-site medical dose order database 32.


In any regard, medical dose order metadata may be stored in corresponding relation to a medication dose order. The medical dose order metadata may include, for example, the following types of data: medication source data indicative of at least one of: a manufacturer of a component of the contained medication unit corresponding to the medication dose order, a lot number of a component of the contained medication unit corresponding to the medication dose order, an expiration date of a component of the contained medication unit corresponding to the medication dose order, a serial number of a component of the contained medication unit corresponding to the medication dose order, or a drug code indicative of the identity of a component of the contained medication unit corresponding to the medication dose order; chain of custody data indicative of at least one of: a listing of entities in possession of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, a listing of users that have taken an action with respect to the contained medication unit corresponding to the medication dose order, wherein the listing of users is correlated to specific actions taken by each user, or tracking information corresponding to physical movement of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order; fulfillment data indicative of at least one of: image data corresponding with a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, scanned data obtained from a component of the contained medication unit corresponding to the medication dose order, analytic data regarding a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, pharmacist review data corresponding with at least one pharmacist review of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, compliance data corresponding with best practices associated with a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, sterility assessment data corresponding to a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, a listing of actions corresponding to a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, time stamp data corresponding to actions corresponding to a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, a listing of life cycle events taken with respect a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, or weight data corresponding to a measured and/or anticipated weight of a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order; or environmental data indicative of at least one of: a temperature to which a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order has been exposed, a temperature to which and corresponding time period for which a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order has been exposed, whether a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order is refrigerated, whether a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order is frozen, a temperature profile experienced by a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order, or accelerometer data corresponding to forces experienced by a component of the contained medication unit corresponding to the medication dose order or the contained medication unit corresponding to the medication dose order.


As may be appreciated from the foregoing description of the medical dose order metadata, a medical dose order may inherit metadata from components used in the preparation of the medical dose order. In a simple example, a medical dose order may include a first component (e.g., a drug) to be mixed with a second component (e.g., a diluent). The first component may have one or more portions of metadata as described above that are associated with the first component. Additionally, the second component may have one or more portions of metadata as described above that are associated with the second component. Thus, a medical dose order that is prepared using the first component and the second component may inherit the metadata from each of the first component and second component. In this regard, a plurality of generations of metadata may be compiled and attributed for a given medical dose order. In an embodiment, metadata for any and all components used to prepare the dose order may be compiled and attributed for a given medical dose order. As such, metadata information for the medical dose order may include metadata originating with source components provided by a manufacturer of the components of a dose order.


The medical dose preparation management system 30 may also be operative to organize 54 dose orders. The organization 54 may include prioritization, scheduling, or other tasks associated with the organization or management of dose orders. The medical dose preparation management system 30 may also be operative to route 56 dose orders to an appropriate work station 40 for use in fulfillment of the dose order. In this regard, a plurality of work stations 40 may be provided in communication with the medical dose preparation management system 30. Different ones of the plurality of work stations 40 may each be suited for different operations related to medical dose order management. As such, depending on the nature of a medical dose, a particular type of work station 40 may be used to prepare the dose. The work station 40 may be on-site relative to the care provider hospital 12 as depicted in FIG. 1 or may be off-site. In this regard, the routing 56 may include communications over a network to a remote work station 40. Furthermore, the system 10 may include a combination of on-site work stations 40 as well as off-site work stations 40 to which dose orders may be routed 56.


In any regard, the medical dose preparation management system 30 may be in operative communication with one or more work stations 40. The routing 56 of dose orders may be at least partially based on one or more factors related to the dose order or the preparation of the dose order. For example, as stated above, the nature of the contained medication unit corresponding to the dose order (e.g., whether a dose order is a chemotherapy dose order, a parenteral dose order, or other specialized dose order) may factor into a determination regarding the routing 56 of the dose order. Additionally or alternatively, the capabilities of the various work stations 40 in relation to the manner in which the dose order is to be prepared may be considered. For example, some orders may require different levels of containment, hooding, or other precautions that may or may not be provided at each work station 40. In an embodiment, other parameters such as technician schedules, work station schedules, work station location, medication dose order scheduling information, or other information may be used alone or in combination to route 56 dose orders to a particular work station 40.


At the work station 40, a work flow corresponding to the preparation of the medical dose order may be displayed 58. In this regard, a work flow that is specific to the medical dose order currently being prepared at the work station 40 may be presented to a technician at the work station 40 to assist or provide guidance to the technician preparing the dose order. Accordingly, the technician may follow a sequence of steps to prepare the medical dose based on the work flow displayed 58 that relates to the dose order.


During and/or after the preparation of the dose order, the work station 40 may be used to assist in obtaining 60 dose order metadata related to the medical dose order. For example, the work station 40 may allow for recording of documentation regarding the preparation of the medical dose such as, for example, acquiring barcode scans of products, capturing medical dose preparation images of medical dose order receptacles during or after use in the preparation of the dose, or obtaining other information related to the preparation of the dose. In an embodiment, one or more of the types of data described above in relation to the medication dose metadata may be acquired in connection with the preparation of the medical dose order at the work station 40.


At least a portion of the dose metadata obtained 60 regarding the medication dose may be stored for viewing by appropriate personnel (e.g., a pharmacist). In this regard, the 20 dose metadata may be utilized to verify 62 the prepared dose prior to the dose being dispensed from the pharmacy 12. In an embodiment, the metadata collected at the work station 40 may be made available to a pharmacist via a network. In this regard, a pharmacist tasked with verifying 62 a dose order may access the information and/or data remotely (e.g., in a location in the hospital but outside the IV room or even entirely remove from hospital premises via the network). The ability to remotely access the metadata may allow the pharmacist to avoid having to enter the IV room to verify 62 a dose order (i.e., thus avoid the potentially burdensome gowning procedures commonly associated with entering the controlled environment of an IV room). The verifying 62 may include inspection of medical dose preparation images, obtained information, or other data regarding the medical dose order by the pharmacist. For example, the pharmacist may verify the correct medication was prepared in the correct manner and/or in the correct amounts based on metadata gathered and stored during the preparation of the medical dose order. If the medication dose order is incorrect in any regard, the pharmacist may request the medication dose order be reworked or restarted.


Once the dose order has been prepared and verified 62, the medical dose preparation management system 30 may dispense 64 the dose order. When dispensing 64 the dose order, the dose order may be dispatched from the pharmacy 12 for administration to a patient by the care provider. For example, the dose may be administered at the care provider hospital 12 or an offsite location under the direction or supervision of the care provider.


The medical dose preparation management system 30 may also facilitate tracking 66 of the dose order to administration to the patient. The pharmacy work flow manager 30 may also retain records associated with each dose that may be stored or archived. For example, the records may be stored digitally in electronically indexed and searchable form. The records may include at least a portion and preferably all metadata regarding each dose.


With further reference to FIG. 2, a schematic view depicting an embodiment of a work station 40 is shown. The work station 40 may include a processor 70 in operative communication with an imaging device 80. The imaging device 80 may be a digital camera operable to output digital image data. The digital image data may comprise still images and/or digital video. In this regard, the imaging device 80 may output a video data stream 82 that is received by the processor 70. In this regard, the processor 70 may include a video data stream processing module 72 for processing the video data stream 82 received at the processor 70 from imaging device 80. While the various components shown in FIG. 2 are shown in direct communication, the various components may also be in operative communication by way of a network interface or the like.


The imaging device 80 may include an imaging field 84. The imaging field 84 may encompass a medical dose preparation staging region 86. The imaging device 80 may be supportably mounted to a base 90. For example, a support 92 may extend from the base 90 to the imaging device 80 to support imaging device 80 relative to the base 80. In this regard, in an embodiment the medical dose preparation staging region 86 may include a support surface 94 of the base 90. The medical dose preparation staging region 86 may also include a volume above the surface 94 (e.g., extending from the surface in a direction normal to the surface and/or toward the imaging device 80). In any regard, the imaging field 84 of the imaging device 80 may encompass the medical dose preparation staging region 86 that may supportably receive a medication receptacle 100. In turn, the imaging device 80, support 92, and base 90 may collectively define a camera stand 190. As such, the camera stand 190 may be used at a work station 40 to support the imaging device 80 relative to the base 90 to obtain medical dose preparation image and/or other metadata during the preparation of the medical dose order.


The medication receptacle 100 supportable by the base 90 in the medical dose preparation staging region 86 may include any material, container, apparatus, or other object that is used in the preparation of a dose. For example, the medication receptacle 100 may be or include a source receptacle, a transference receptacle, or an administration receptacle. A source receptacle may store a medication product as stored in the pharmacy prior to compounding or dose preparation. In this regard, the source receptacle may be a receptacle as packaged by and received from a drug manufacturer. As such, the source receptacle may include information thereon relating to the medication. For example, the product name, concentration, amount, lot information, expiration information, a serial number, other manufacturing information or other information may be associated with the medication and/or may appear on the source receptacle. The medical dose preparation management system 30 may be operable to store metadata regarding the source receptacle including any of the foregoing portions of data that may appear on the source receptacle. In this regard, the source receptacle may be identifiable by the work station 40 (e.g., via the use of a machine readable indicium such as a bar code or the like).


Furthermore, the medical dose preparation management system 30 may be operable to attribute metadata from the source receptacle to the dose order in which the source receptacle is used as described above. The source receptacle metadata may even be attributed to or appended to the metadata for the medical dose order when the source receptacle comprises a pre-prepared medication that has been compounded at the pharmacy and disposed in the source receptacle for later use in the preparation of a dose. In this regard, the metadata for several generations of components used to prepare a medical dose order (e.g., originating from original source components received from a manufacturer such as a drug manufacturer) may be attributed to the medical dose order. As such, the medical dose order metadata may include information regarding all components used in the medical dose order including inherited metadata. The metadata for the various components may be retrieved upon identification of the receptacle 100 at the work station 40 (e.g., by way of scanning a machine readable indicium). In various embodiments, the source receptacle may include a vial, a syringe, a bottle, a bag, or other appropriate medication receptacle known in the art.


An administration receptacle may be any receptacle used during the administration of the medical dose to the patient. The administration receptacle may contain any medication, diluent, supplement, or any other material to be administered to the patient. In various embodiments, the administration receptacle may include a syringe, an IV bag, or other appropriate medication receptacle used in the administration of a substance to patient. An administration receptacle may also include metadata that is included in the metadata for the prepared medical dose order.


The transference receptacle may be used to transfer a substance from a source receptacle to the administration receptacle. For example, the transference receptacle may be a syringe or any other appropriate receptacle known in the art capable of transferring a substance from the source receptacle to the administration receptacle. A transference receptacle may also include metadata that is included in the metadata for the prepared medical dose order.


Returning to FIG. 2, the processor 70 may be in further operative communication with a display 110. In this regard, the video data stream 82 received from the imaging device 80 may be displayed on the display 110 in a manner that is perceivable by user. The video data stream 82 displayed on the display 110 may be processed by way of the video data stream processing module 72. For example, the video data stream processing module 72 may be operable to capture still images from the video data stream 82. The video data stream 82 may include a series of images displayed at a given frame rate. For example, the frame rate may be 5-10 frames/second. In another embodiment, the imaging device 80 may provide still images to the processor 70. In this regard, it may be appreciated that the discussion presented below, while described in the context of processing video data stream 82, may also be performed in the context of still digital images (e.g., on images one at a time when requested in response to a user command or the like).


The video data stream processing module 72 of the processor 70 may also be operative to capture a medical dose preparation image from the video data stream 82 received from the imaging device 80. Medical dose preparation images captured by the video data stream processing module 72 may include one or more medication receptacles 100 used in the course of preparing a medical dose order. In this regard, the preparation of medical dose orders may be documented by capturing images of the medication receptacles 100 used to prepare the dose. The medical dose preparation images may be stored as metadata regarding the medical dose order. A medical dose preparation image may include one or more medication receptacles at various stages during the preparation of the dose. For example, a source receptacle, a transference receptacle, or an administration receptacle may be imaged before, during or after preparation of the dose.


The medical dose preparation images captured by the video data stream processing module 72 may be stored in a memory 120 in operative communication with the processor 70. In this regard, the medical dose preparation images may be stored locally in the memory 120 at the work station 40. Additionally or alternatively, the medical dose preparation images may be communicated to a remote location (e.g., an on-site medication dose order database 32 or an off-site medication dose order database 34 shown in FIG. 1) by way of a network interface 140 in operative communication with the processor 70. In any regard, medical dose preparation images may be accessible such that images may be later reviewed in the course of verifying (e.g., the verifying 62 described above in relation to FIG. 1) the medical dose order and/or for maintaining records regarding the dose orders prepared by the work station 40 and/or the hospital pharmacy 12 generally.


The processor 70 may also be in operative communication with a user control device 130. The user control device 130 may be operable to receive an input from a user (e.g., a pharmacy technician preparing a dose). The user control device 130 may be, for example, a foot pedal, a button, a touch screen, a mouse, a keyboard, or other user input device known in the art. A user may utilize the user control device 130 to trigger the capture of a medical dose preparation image from the video data stream 82. For example, a medication receptacle 100 may be viewed by the user by observing the display 110 displaying the video data stream 82 captured by the imaging device 80 of imaging field 86 including the medication receptacle 100. Once the image displayed on the display 110 is acceptable to the user, the user may use the user control device 130 to trigger the capture of the medical dose preparation image for storage in the memory 120 or in a remote database as described above.


The work station 40 may also include a printer 150 that is operative to print dose labels associated with a medical product, a dose that is in progress, and/or a completed dose. In this regard, the printer 150 may be a label printer operative to print labels used in the pharmacy 12 and/or hospital in connection with metal doses and/or medical dose orders.


It may be appreciated that in the course of preparing medical dose orders in a hospital 12, the number of medical dose preparation images captured in connection with dose orders may be extremely large. For example, a plurality of images may be captured in connection with each dose prepared. For most hospitals, the number of doses prepared daily may be on the order of hundreds of doses or more. In this regard, the memory resources necessary to store images captured in connection with the preparation of medical dose orders may be large, especially considering the practice of hospitals of storing archived images for dose orders.


Furthermore, because medical dose preparation images may be used by a pharmacist to verify medical dose orders prior to dispensing orders from the pharmacy, image resolution may be at a premium in order to facilitate accurate review by the pharmacist of images. Accordingly, the need for large memory resources dedicated to storing medical dose preparation images is exacerbated. Accordingly, any reduction in image size (e.g., as represented by the size of the image in memory) may be advantageous to reduce the memory resources required for storage of images and/or to allow more efficient use of memory resources available for the storage of medical dose preparation images.


As such, capturing medical dose preparation images including the entire imaging field 86 may be an inefficient use of memory resources. Cropping images to retain relevant portions of the imaging field 86 (i.e., those containing medication receptacles 100) for storage may be a more efficient use of memory resources than storing an image of the entire imaging field 86. For example, for a given resolution, the overall image dimensions may be reduced to reduce the size in memory of the image. Additionally or alternatively, for an image with reduced overall dimensions, the image resolution may be increased without an increase in the size of the image in memory compared to an image of the entire imaging field 84 at a reduced resolution.


However, requiring an operator to manually crop each image of the imaging field 86 may add time to the preparation of medical dose orders. This may result in increased costs associated with preparation of medical disorders or be undesirable based on scheduling requirements for doses, especially “stat” doses that may be critical to the life of a patient. In this regard, the video data stream processing module 72 may be operative to perform an auto cropping operation on the video data stream 82 acquired by the imaging device 80 so as to identify relevant portions of the video data stream 82 for storage to reduce the memory resources needed to store medical dose preparation images while not impacting the speed of the preparation of medical dose orders.


In an embodiment, an auto cropping operation may involve comparing the video data stream 82 with a background image to identify a region of interest corresponding to an object disposed in the imaging field in the video data stream 82. With further reference to FIG. 3, an example of a still image representing one instance in time of the video data stream 82 acquired by the imaging device 80 of the medical dose preparation staging region 86 is depicted. The medical dose preparation staging region 86 may include medication receptacle engagement features such as grooves 88, channels 89, or other features adapted to engage medication receptacles 100 to retain medication receptacles 100 stationary in the medical dose preparation staging region 86. In FIG. 3, no medication receptacles 100 are present such that the medical dose preparation staging region 86 is devoid of any objects. This image may be captured as a background image 200 that depicts the appearance of the medical dose preparation region 86 in video data stream 82 when no medication receptacles 100 are present. Of note, the base 90 may extend across the entire imaging field 84 to occupy substantially all of the background in the image field 84. The background image 200 may be compared during the auto cropping operation to a video data stream 82 from the imaging device 80. The background image may be stored remotely or locally (e.g., in the memory 120 of the work station in a background image store 124).


In an embodiment, a plurality of background images 200 may be obtained such that different ones of the plurality of background images 200 are employed in the auto cropping operation depending upon the location and/or orientation of the imaging device 80. For example, the imaging device 80 may be positionable in a plurality of positions. Accordingly, depending upon the position of the imaging device 80, the background image 200 may differ.


In this regard, a sensor may be provided to determine the position in which the imaging device 80 disposed such an appropriate corresponding one of the plurality of background images may be used based on the identified position of the imaging device 80.


In any regard, after a background image 200 has been attained, one or more medication receptacles 100 may be disposed in the medical dose preparation staging region 86 as depicted in FIG. 4. For example, as shown in FIG. 4, a syringe 100a and a vial 100b have been disposed in the medical dose preparation staging region 86. As can be appreciated, the medication receptacle engagement features (88, 89) may at least generally correspond to the medication receptacles 100 disposed in the medical dose preparation staging region 86. In any regard, the video data stream 82 obtained from the imaging device may now include the medication receptacles 100a and 100b as shown in FIG. 4. The auto cropping operation may generally include comparing the background image 200 obtained of the medical dose preparation staging region 86 without medication receptacles 100 disposed thereon to the video data stream 82 including medication receptacles 100 having been disposed in the medical dose preparation staging region 86 to determining regions of interest corresponding to the medication receptacles 100.


In this regard, upon analysis of the differences between the background image 200 and video data stream 82, a plurality of locations representing differences between the video data stream 82 and the background image 200 corresponding to the medication receptacles



20
100 may be determined such that regions of interest encompassing the medication receptacles 100 may be determined. In turn, the medical dose preparation images captured may contain image data corresponding only to the regions of interest identified including the medication receptacles 100 and may exclude a portion or all of the imaging field 86 outside the region of interest.



25 In an embodiment, a subset (e.g., a predetermined subset) of the video data stream



82 may be compared to a corresponding subset of the background image 200 to identify differences between the video data stream 82 and the background image 200 corresponding to the presence of medication receptacles 100. By comparing only a subset of the video data stream 82 against a corresponding subset of the background image 200, the amount of data to be processed may be reduced such that the auto cropping operation may occur more quickly to prevent the slowing of the preparation of medical doses.


In this regard, the auto cropping operation described herein may occur substantially faster than a method where every pixel of an image is analyzed to determine differences between a video data stream 82 and a background image 200. As such, the auto crop operation described herein may provide an accurate automatic crop operation with a very fast execution time. For example, the auto crop operation described herein may occur for a given frame of the video data stream 82 prior to obtaining the next frame in the video data stream 82. For example, in the embodiment where the imaging device 80 to collects video at 5-10 frames per second, the auto cropping operation may be completed faster than the frame rate of the imaging device 80 (i.e., at least within 100 ms for a frame rate of 10 frames/second). That is, the auto cropping algorithm may execute in a time less than the refresh rate of the video data stream. In this regard, the auto cropping operation may identify a region of interest for each image in the video data stream 82 prior to obtaining the next image in the video data stream 82.


With reference to FIG. 5, an embodiment of a potential subset of the video data stream 82 is shown that may correspond to selected pixels of the video data stream 82. For example, the pixels comprising the subset of the video data stream 82 may be taken along a plurality of horizontal grid lines 210 and a plurality of vertical grid lines 212 as depicted in FIG. 5. As such, the horizontal grid lines 210 may extend in a first direction corresponding to the width of the medical dose preparation staging region 86. For example, the horizontal grid lines 210 may extend across substantially the entire width of the medical dose preparation staging region 86 and/or the entire width of the imaging field 86. The vertical grid lines 212 may extend in a second direction corresponding to the length of the medical dose preparation staging region 86. For example, the vertical grid lines 212 may extend across substantially the entire length of the medical dose preparation staging region 86 and/or the entire length of the imaging field 86.


The grid lines 210 and 212 may extend in at least two directions over the imaging field such that the length and the width of a region of interest may be determined relative to the grid lines 210 and 212. With further reference FIG. 6, a corresponding predetermined subset of pixels taken along grid lines 210′ and 212′ in the background image 200 corresponding to grid lines 210 and 212 shown in FIG. 5 may be used in the comparison.


The grid spacing of the predetermined portion of the video data stream 82 and the background image 200 may be selected based on the smallest object anticipated to be imaged. For example, the spacing of the grid lines 210, 212 may be selected such that the least two grid lines 210, 212 cross any medication receptacle 100 that may be placed in the medical dose preparation staging region 86 such that the extent of the bounding area may be accurately determined for each medication receptacle 100.


With additional reference to FIGS. 7-10, the data compared during the auto cropping operation may correspond to data extracted from each pixel along each grid line of the video data stream and the background image. For example, FIG. 7 shows a medication receptacle 100 that has been disposed in the imaging field 86. For purposes of illustration, a single horizontal line 300 is shown which intersects the lateral edges 102 and 104 of the medication receptacle 100.


The video data stream processing module 72 may extract color bitmap data along the horizontal line 300. The video data stream processing module 72 may convert the data for each pixel taken along the horizontal line 300 into an array of grayscale data corresponding to intensity data for each pixel. In one embodiment, the video data stream processing module 72 may convert grayscale data for each pixel into a quantitative value representing the relative color of the grayscale data for each pixel between white and black. For example, an 8 bit value may be established on a scale of 0-255 where zero represents black and 255 represents white for a pixel. Accordingly, the intensity data for each pixel may correspond to a value representative of the pixels location in the grayscale between white and black.


Various processing techniques may be applied to the intensity data of the pixels taken along the horizontal line. For example, a transform of the data into the frequency domain using a mathematical transform (e.g., fast Fourier transform (FFT)) may be applied to the intensity data. FIG. 8 depicts the results one example of an FFT of data taken along the horizontal line 300 from FIG. 7. A first line 310 corresponds to data from the video data stream 82 depicted in FIG. 7 including the medication receptacle 100 and a second line 312 corresponds to data from a corresponding horizontal line in a background image of the imaging field of FIG. 7 without the medication receptacle 100.


As can be appreciated from FIG. 8, significant low-frequency content up until about 5% full frequency is present. Any deviation of the first line 310 from the second line 312 in the higher frequencies may result from effects of the FFT process and may not be real. Accordingly, a high pass cutoff frequency may be established to effectively eliminate low-frequency intensity changes. The threshold for high pass filter may be selected considering that too low a high pass filter threshold may eliminate robustness against lighting changes, which will mostly show up as low-frequency data in the FFT plot.


With further reference to FIG. 9, the raw intensity data for pixels taken along the horizontal line 300 of the video data stream shown in FIG. 7 is plotted using plot line 320 and raw intensity data for pixels taken along a corresponding horizontal line of a background image is plotted using plot line 322. The vertical axis of the plot in FIG. 9 represents intensity data (e.g., quantified grayscale data as described above) and the horizontal axis represents pixel location along the horizontal line of FIG. 7. Vertical lines 324 and 326 in FIG. 9 represent the location in the plot of FIG. 9 of the lateral edges 102 and 104, respectively, of the medication receptacle 100 shown in FIG. 7. As may be appreciated, the deviation between the video data stream plot line 320 and the background image plot line 322 may not include sharp edges such that the location of the edges 102, 104 of the medication receptacle 100 may be difficult to detect using the raw intensity data.


However, FIG. 10 (whose axes also represent deviation in intensity along the vertical axis and pixel location on the horizontal axis) depicts a similar plot having undergone high pass filtering. As may be appreciated, the deviations at the left edge 102 (represented by vertical line 324) and at the right edge 104 (represented by vertical line 326) of the medication receptacle 100 are more pronounced such that the edge 102, 104 of the medication receptacle 100 may be detected. Note that this is even the case on the left lateral edge 102 of the medication receptacle 100 were no label is present at the edge 102 in the video data image of FIG. 7. In this regard, the left edge 102 represents a “soft edge.” The term “soft edge” is intended to denote a situation where an edge of the medication receptacle 100 does not have a label portion present at the edge as is shown on the left side 102 of the medication receptacle 100 in FIG. 7. That is, a soft edge may correspond to a completely translucent or transparent edge portion of the medication receptacle 100. It may be appreciated such soft edges may present less pronounced differences between the video data stream data in the background image data as can be appreciated in comparing the deviations on the left side (324) and right side (326) of the plot in FIG. 10, respectfully. However, upon inspection of the filter data in FIG. 10, the edges of the medication receptacle 100 are clearly denoted and may be identified.


Furthermore, processing may be performed on the intensity data for each pixel to assist in improving the accuracy of the auto cropping operation. For example, the intensity data may be filtered using any number of additional or alternative filtering techniques known the art.


Additionally, the rate of change of the intensity along each grid line 210, 212 rather than raw intensity data for each pixel may provide a more accurate measure of the presence or absence of a medication receptacle 100 disposed in a medical dose preparation staging region 86. In this regard, the derivative of the raw intensity data 320 may be calculated to reflect the rate of change of intensity along each grid line 210, 212 to assist in determining the location of an edge of a medication receptacle 100 disposed in the medical dose preparation staging region 86.


Furthermore, during the correlation of the subset of the video data stream 82 with the background image 200, each pixel of the video data stream 82 may be compared to a directly corresponding pixel in the background image 200 or each pixel of the video data stream 82 may be compared to a plurality of pixels within a certain predetermined distance along the corresponding grid line in the background image 200 of a directly corresponding pixel. For example, any given pixel for the video data stream 82 may be compared to pixels within about +/−10 pixels of the directly corresponding pixel in the background image 200. Thus, slight variations between the position of the background image 200 relative to the video data stream 82 and/or minor lighting variations may be accommodated that may otherwise be attributed to identified edges of medication receptacles 100. For example, the video data stream 82 corresponding to the background image 200 may move slightly and/or be subject to slightly different lighting such that minor variations may occur. However, by comparing a given pixel in the video data stream 82 with a range of pixels in the corresponding background image 200, and minor variations may be accounted for.


Based on the analysis of the video data stream 82 in relation to the background image 200, the edges of a given medication receptacle 100 may be determined along each grid line 210, 212. For example, a difference identified along a grid line 210, 212 that exceeds a predetermined rate of change may be attributed to a location 370 of an edge of a medication receptacle 100. Based on the locations 370 at each grid line 210, 212 corresponding to determined edges of medication receptacles 100, a bounding area 360 (e.g., as shown in FIG. 11). The bounding area 360 may be comprised of edges 362 that may be located in correspondence to identified locations 370 of the edges of a medication receptacle 100 in the video data stream 82. For example, the minimum and maximum location 370 determined along each of the horizontal grid lines 210 hits may be used to determine a horizontal position of the edges 362 of the bounding area 360. In an implementation, the minimum and maximum location 370 determined along each vertical grid line 212 may be used to determine the vertical position of the edges 362 of the bounding area 362. Furthermore, in an embodiment, the edges 362 of the bounding area 360 may be extended beyond the minimum and maximum locations 370 in both the vertical and horizontal direction to the next grid line beyond the minimum and maximum location 370. For example, a medication receptacle 100 may extend beyond a grid line 210 or 212 such that a location 370 is identified. While the medication receptacle 100 may extend beyond a grid line 210 or 212, the receptacle 100 may not extend to the next adjacent grid line. Thus, if the bounding area 360 were to be established at the location 370, a portion of the medication receptacle 100 may not be included within the bounding area 360. As such, the bounding area 360 may be automatically expanded to include the area up to the next adjacent grid line in both the horizontal and vertical directions beyond the minimum and maximum identified location 370 for a given medication receptacle 100.


With further reference to FIG. 11, by comparing the background image 200 to a video data stream 82 along the predetermined subset of the video data stream 82 and background image 200, locations 370 corresponding to differences between the background image 200 and video data stream may be located in the manner described above. In turn, locations 370 along the grid lines 210 and 212 may be identified as indicated in FIG. 11 that correspond to the minimum and maximum locations of differences between the video data stream 82 and the background image 200 along both the horizontal and vertical grid lines 210 and 212. Based on these locations 370, edges 362 of a bounding area 360 may be established around each medication receptacle 100.


As may further be appreciated in FIG. 11, more than one medication receptacle 100 may be disposed in the imaging field 86 at any one time. The video stream data processing module 72 may be operative to separately identify the plurality of medication receptacles 100 such that discrete bounding areas 360 are established for each medication receptacle 100 individually. While two medication receptacles 100 are depicted in FIG. 11, it may be appreciated that additional or fewer medication receptacles 100 may be identified such that additional or fewer corresponding bounding areas 360 are established by the video data stream processing module 72 of the processor 70.


In this regard, the auto cropping operation may include logic to individually identify different medication receptacles 100 disposed in imaging field 86. For example, logic may be employed wherein if a certain predetermined distance along a grid line 210, 212 does not have any differences compared to the background image 200, the locations 370 at the extends of a distance exceeding the predetermined distance may be attributed to separate medication receptacles 100. Additionally or alternatively, an analysis may be performed to identify a perimeter of a medication receptacle 100 such that individual medical receptacles 100 may be identified based on identification of a unitary closed perimeter. For example, for a given close perimeter, the auto cropping operation may determine a single medication receptacle 100 exists and dedicate a single bounding box to the identified medical receptacle 100.


With further reference FIG. 12, an example of the output of the display 110 is shown. It may be appreciated that the grid lines 210 and 212 corresponding to the subset of the video data stream 82 analyzed to determine the bounding areas 360 may not be shown on the display 110. However, the bounding areas 360 may be represented on the display 110 such that the region of interest identified by the video data stream processing module 72 may be perceivable by a user viewing the display 110. In this regard, once the bounding area 360 has been established for each of the medication receptacles 100, the display 110 may be configured to display the bounding area 360 in relation to the video data stream 82 on the display 110 such that the user may verify that the bounding area 360 includes all relevant portions of the medication receptacle 100 in the bounding area 360.


The user may have the opportunity to expand or contract the bounding area 360 displayed to increase or decrease the size of the region of interest surrounding a medication receptacle 100 in the video data stream 82. In an embodiment, if the bounding box 320 is incorrectly determined by the auto cropping operation the user may employ a marker or other object disposed in the medical dose preparation staging area 86 that provides a high contrast to the background 200 to establish an edge location 370 for a bounding area 360. For example, an object may be disposed adjacent to the medication receptacle 100 to positively establish an edge 362 of the bounding area 360 beyond the extent of the medication receptacle 100. The object may be a discrete object such as a marker or the like that is placed in the imaging field 86, or the user may employ his or her finger or other pointing device disposed in imaging field 86 to positively establish a location 370.


Once the region of interest has been established by the user, the user may utilize the user control device 130 to initiate the capture of medical dose preparation images corresponding to the portion of the video data stream 82 included in the bounding box 320 (i.e., the region of interest). For example, FIGS. 13 and 14 depict the medical dose preparation images corresponding to the two medication receptacles 100a and 100b, respectively, contained in the video data stream 82 depicted on the display 110 shown in FIG. 12 that may be captured upon the user utilizing the user control device 130 to initiate capture of the images when the bounding areas 360 are establish as shown in FIG. 12.


In an embodiment, the bounding area 360 may be represented a box superimposed over the video data stream 82 in a manner perceivable by the user. Additionally or alternatively, the area outside the bounding area 360 not to be included in the medical dose preparation image may be displayed in a manner different than the area within the bounding area 360 to be included in the medical dose preparation image. For example, the area of the imaging field 86 outside a bounding area 360 may be displayed as a dimmed or shadowed image that clearly identifies to the user that the area outside the bounding areas 360 is to be not included in the medical dose preparation image.


While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description is to be considered as exemplary and not restrictive in character. For example, certain embodiments described hereinabove may be combinable with other described embodiments and/or arranged in other ways (e.g., process elements may be performed in other sequences). Accordingly, it should be understood that only the preferred embodiment and variants thereof have been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.


The foregoing description of the present invention has been presented for purposes of illustration and description. Furthermore, the description is not intended to limit the invention to the form disclosed herein. Consequently, variations and modifications commensurate with the above teachings, and skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described hereinabove are further intended to explain known modes of practicing the invention and to enable others skilled in the art to utilize the invention in such or other embodiments and with various modifications required by the particular application(s) or use(s) of the present invention. It is intended that the appended claims be construed to include alternative embodiments to the extent permitted by the prior art.

Claims
  • 1. A work station for use in a system for medical dose preparation management, the work station comprising: a base;a medication preparation staging region disposed relative to the base and operable to supportively engage at least one medication receptacle;an imaging device having an imaging field encompassing at least a portion of the medication preparation staging region, wherein the imaging device is operable to output a video data stream of the imaging field;a processor in operative communication with the imaging device to receive the video data stream of the imaging field;a user control device in operative communication with the processor to initiate a capture of a medical dose preparation image from the video data stream in response to a user input received at the user control device;a scale in operative communication with the processor and operable to output a weight corresponding to a medication receptacle that is supportably disposed in the medication preparation staging region; anda memory in operative communication with the processor,wherein upon receipt of the user input, the weight is recorded by the processor from the scale at substantially the same time as the capture of the medical dose preparation image, and wherein the weight and the medical dose preparation image are associatively stored in the memory.
  • 2. The work station of claim 1, wherein the processor is operable to compare the weight to an anticipated weight of the medication receptacle.
  • 3. The work station of claim 2, wherein the processor is operable to calculate a deviation of the weight to the anticipated weight.
  • 4. The work station of claim 3, wherein the deviation is associatively stored in the memory with the weight and the medical dose preparation image.
  • 5. The work station of claim 4, wherein the deviation is compared to a threshold deviation, and wherein when the deviation exceeds a threshold deviation, an alert is provided to a user.
  • 6. The work station of claim 1, wherein the base, the imaging device, and the scale are interconnected for movement as a single unit.
  • 7. The work station of claim 1, where the scale is included in the base.
  • 8. The work station of claim 1, further comprising: a housing, wherein the imaging device is located at least partially within the housing; and,a support member extending between the base and the housing for supportably disposing the imaging device relative to the base.
  • 9. The work station of claim 8, further comprising: an umbilical at least partially disposed within the support member, wherein the umbilical includes at least one of a signal communication path and a power communication path; andat least one light source disposed in the housing, wherein the at least one light source is operable to emit light from the housing in a direction toward the medication preparation staging region.
  • 10. The work station of claim 8, wherein the housing includes an opening, wherein the imaging device is disposed in a central region of the housing opening and a peripheral region extends about the central region, and wherein a plurality of light sources are disposed in the peripheral region.
  • 11. The work station of claim 8, wherein an intensity of the at least one light source is automatically modified from a default intensity of light emitted to a modified intensity of light emitted at a first predetermined period after the capture of the medical dose preparation image.
  • 12. The work station of claim 1, wherein the base comprises: a support platform at least partially defining the medication preparation staging region.
  • 13. The work station of claim 12, wherein the base further comprises: a platform base, wherein the support platform is removably disposed relative to the platform base.
  • 14. The work station of claim 1, wherein the base comprises: a platform base, wherein the scale is included in the platform base, and wherein the scale comprises load cells disposed in the platform base.
  • 15. The work station of claim 14, further comprising: a support platform defining the medication preparation staging region, wherein the load cells are disposed adjacent to the support platform.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/339,390, filed Oct. 31, 2016, entitled “IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” which is a continuation of U.S. patent application Ser. No. 14/438,544, filed Apr. 24, 2015, now U.S. Pat. No. 9,489,489, entitled “IMPROVED IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” which is a U.S. National Stage of International Patent Application No. PCT/US2013/032497, filed Mar. 15, 2013, entitled, “IMPROVED IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” which claims benefit of priority to U.S. Provisional Patent Application No. 61/719,235 filed Oct. 26, 2012, entitled “IMPROVED IMAGE ACQUISITION FOR MEDICAL DOSE PREPARATION SYSTEM,” all of which foregoing patent applications are incorporated herein by reference in their entirety.

US Referenced Citations (1338)
Number Name Date Kind
641748 Smith Jan 1900 A
819339 Cleland May 1906 A
3426150 Tygart Feb 1969 A
3739943 Williamsen et al. Jun 1973 A
3742938 Stern Jul 1973 A
3756752 Stenner Sep 1973 A
3774762 Lichtenstein Nov 1973 A
3786190 Pori Jan 1974 A
3809871 Howard et al. May 1974 A
3810102 Parks, III et al. May 1974 A
3848112 Weichselbaum et al. Nov 1974 A
3858574 Page Jan 1975 A
3878967 Joslin et al. Apr 1975 A
3910257 Fletcher et al. Oct 1975 A
3910260 Sarnoff et al. Nov 1975 A
3921196 Patterson Nov 1975 A
3971000 Cromwell Jul 1976 A
3995630 Verrdonk Dec 1976 A
3998103 Bjorklund et al. Dec 1976 A
4032908 Rice et al. Jun 1977 A
4078562 Friedman Mar 1978 A
4144496 Cunningham et al. Mar 1979 A
4151407 McBride et al. Apr 1979 A
4156867 Bench et al. May 1979 A
4164320 Irazoqui et al. Aug 1979 A
4173971 Karz Nov 1979 A
4199307 Jassawalla Apr 1980 A
4270532 Franetzki et al. Jun 1981 A
4273121 Jassawalla Jun 1981 A
4282872 Franetzki et al. Aug 1981 A
4308866 Jelliffe et al. Jan 1982 A
4319338 Grudowski et al. Mar 1982 A
4320757 Whitney et al. Mar 1982 A
4354252 Lamb et al. Oct 1982 A
4369780 Sakai Jan 1983 A
4370983 Lichtenstein Feb 1983 A
4373527 Fischell Feb 1983 A
4381776 Latham, Jr. May 1983 A
4385630 Gilcher et al. May 1983 A
4398289 Schoate Aug 1983 A
4398908 Siposs Aug 1983 A
4414566 Peyton et al. Nov 1983 A
4416654 Schoendorfer et al. Nov 1983 A
4425114 Schoendorfer et al. Jan 1984 A
4428381 Hepp Jan 1984 A
4443216 Chappell Apr 1984 A
4447224 DeCant, Jr. et al. May 1984 A
4449538 Corbitt et al. May 1984 A
4451255 Bujan et al. May 1984 A
4457750 Hill Jul 1984 A
4458693 Badzinski et al. Jul 1984 A
4460358 Somerville et al. Jul 1984 A
4464172 Lichtenstein Aug 1984 A
4469481 Kobayashi Sep 1984 A
4475901 Kraegen et al. Oct 1984 A
4476381 Rubin Oct 1984 A
4480751 Lueptow Nov 1984 A
4481670 Freeburg Nov 1984 A
4487604 Iwatschenko et al. Dec 1984 A
4490798 Franks et al. Dec 1984 A
4496351 Hillel et al. Jan 1985 A
4511352 Theeuwes et al. Apr 1985 A
4525861 Freeburg Jun 1985 A
4526574 Pekkarinen Jul 1985 A
4529401 Leslie et al. Jul 1985 A
4531527 Reinhold, Jr. et al. Jul 1985 A
4538138 Harvey et al. Aug 1985 A
4545071 Freeburg Oct 1985 A
4551133 Zegers de Beyl et al. Nov 1985 A
4559038 Berg et al. Dec 1985 A
4560979 Rosskopf Dec 1985 A
4561443 Hogrefe et al. Dec 1985 A
4562751 Nason Jan 1986 A
4564054 Gustaysson Jan 1986 A
4590473 Burke et al. May 1986 A
4602249 Abbott Jul 1986 A
4619653 Fischell Oct 1986 A
4622979 Katchis et al. Nov 1986 A
4624661 Arimond Nov 1986 A
4636950 Caswell et al. Jan 1987 A
4637817 Archibald et al. Jan 1987 A
4650469 Berg et al. Mar 1987 A
4652262 Veracchi Mar 1987 A
4653010 Figler et al. Mar 1987 A
4676776 Howson Jun 1987 A
4681563 Deckert et al. Jul 1987 A
4688167 Agarwal Aug 1987 A
4691580 Fosslien Sep 1987 A
4695954 Rose et al. Sep 1987 A
4696671 Epstein et al. Sep 1987 A
4697928 Csongor Oct 1987 A
4702595 Mutschler et al. Oct 1987 A
4705506 Archibald Nov 1987 A
D293135 Medema et al. Dec 1987 S
4714462 DiComenico Dec 1987 A
4717042 McLaughlin Jan 1988 A
4718576 Tamura et al. Jan 1988 A
4722224 Scheller et al. Feb 1988 A
4722349 Baumberg Feb 1988 A
4722734 Kolln Feb 1988 A
4730849 Siegel Mar 1988 A
4731058 Doan Mar 1988 A
4732411 Siegel Mar 1988 A
4741732 Crankshaw et al. May 1988 A
4741736 Brown May 1988 A
4756706 Kerns et al. Jul 1988 A
4759756 Forman Jul 1988 A
4770184 Greene et al. Sep 1988 A
4778449 Weber et al. Oct 1988 A
4779626 Peel et al. Oct 1988 A
4784645 Fischell Nov 1988 A
4785799 Schoon et al. Nov 1988 A
4785969 McLaughlin Nov 1988 A
4796644 Polaschegg Jan 1989 A
4797840 Fraden Jan 1989 A
4803625 Fu et al. Feb 1989 A
4810090 Boucher Mar 1989 A
4810243 Howson Mar 1989 A
4811844 Moulding, Jr. et al. Mar 1989 A
4816208 Woods et al. Mar 1989 A
4817044 Ogren Mar 1989 A
4828545 Epstein et al. May 1989 A
4829524 Yoshida May 1989 A
4830018 Treach May 1989 A
4831562 Mcintosh et al. May 1989 A
4832033 Maher et al. May 1989 A
4835372 Gombrich et al. May 1989 A
4835521 Andrejasich et al. May 1989 A
4838275 Lee Jun 1989 A
4839806 Goldfischer et al. Jun 1989 A
4845644 Anthias et al. Jul 1989 A
4847764 Halvorson Jul 1989 A
4850009 Zook et al. Jul 1989 A
4850972 Schulman et al. Jul 1989 A
4853521 Claeys et al. Aug 1989 A
4854324 Hirschman et al. Aug 1989 A
4857713 Brown Aug 1989 A
4857716 Gombrich et al. Aug 1989 A
4865584 Epstein et al. Sep 1989 A
4871351 Feingold Oct 1989 A
4878175 Norden-Paul et al. Oct 1989 A
4880013 Chio Nov 1989 A
4889132 Hutcheson et al. Dec 1989 A
4889134 Greenwold et al. Dec 1989 A
4893270 Beck et al. Jan 1990 A
4897777 Janke et al. Jan 1990 A
4898209 Zbed Feb 1990 A
4898576 Philip Feb 1990 A
4898578 Rubalcaba, Jr. Feb 1990 A
4901728 Hutchison Feb 1990 A
4905163 Garber et al. Feb 1990 A
4908017 Howson et al. Mar 1990 A
4912623 Rantala et al. Mar 1990 A
4916441 Gombrich et al. Apr 1990 A
4922922 Pollock et al. May 1990 A
4925444 Orkin et al. May 1990 A
4933843 Scheller et al. Jun 1990 A
4937777 Flood et al. Jun 1990 A
4941808 Qureshi et al. Jul 1990 A
4943279 Samiotes et al. Jul 1990 A
4943987 Asahina et al. Jul 1990 A
4946445 Lynn Aug 1990 A
4949274 Hollander et al. Aug 1990 A
4952928 Carroll et al. Aug 1990 A
4953074 Kametani et al. Aug 1990 A
4960230 Marelli Oct 1990 A
4964847 Prince Oct 1990 A
4966579 Polaschegg Oct 1990 A
4967928 Carter Nov 1990 A
4968295 Neumann Nov 1990 A
4975647 Downer et al. Dec 1990 A
4977590 Milovancevic Dec 1990 A
4978335 Arthur, III Dec 1990 A
4991091 Allen Feb 1991 A
4992926 Janke et al. Feb 1991 A
4993068 Piosenka et al. Feb 1991 A
4993506 Angel Feb 1991 A
4998249 Bennett et al. Mar 1991 A
5002055 Merki et al. Mar 1991 A
5003296 Lee Mar 1991 A
5006699 Felkner et al. Apr 1991 A
5007429 Treatch et al. Apr 1991 A
5012402 Akiyama Apr 1991 A
5012411 Policastro et al. Apr 1991 A
5014875 McLaughlin et al. May 1991 A
5016172 Dessertine May 1991 A
5023770 Siverling Jun 1991 A
5025374 Roizen et al. Jun 1991 A
5036852 Leishman Aug 1991 A
5038800 Oba Aug 1991 A
5041086 Koenig et al. Aug 1991 A
5045048 Kaleskas et al. Sep 1991 A
5047959 Phillips et al. Sep 1991 A
5053031 Borsanyi Oct 1991 A
5053990 Kreifels et al. Oct 1991 A
5055001 Natwick et al. Oct 1991 A
5057076 Polaschegg Oct 1991 A
5061243 Winchell et al. Oct 1991 A
5072356 Watt et al. Dec 1991 A
5072383 Brimm et al. Dec 1991 A
5072412 Henderson, Jr. et al. Dec 1991 A
5078683 Sancoff et al. Jan 1992 A
5084828 Kaufman et al. Jan 1992 A
5087245 Doan Feb 1992 A
5088904 Okada Feb 1992 A
5088981 Howson et al. Feb 1992 A
5088990 Hivale et al. Feb 1992 A
5096385 Georgi et al. Mar 1992 A
5098377 Borsanyi et al. Mar 1992 A
5100380 Epstein et al. Mar 1992 A
5100394 Dudar et al. Mar 1992 A
5103211 Daoud et al. Apr 1992 A
5104374 Bishko et al. Apr 1992 A
5108131 Nassim Apr 1992 A
5108363 Tuttle et al. Apr 1992 A
5108367 Epstein et al. Apr 1992 A
5108372 Swenson Apr 1992 A
5109487 Ohgomori et al. Apr 1992 A
5109849 Goodman et al. May 1992 A
5112319 Lai May 1992 A
5116203 Natwick et al. May 1992 A
5116312 Blankenship et al. May 1992 A
5131092 Sackmann et al. Jul 1992 A
5134574 Beaverstock et al. Jul 1992 A
5135500 Zdeb Aug 1992 A
5137023 Mendelson et al. Aug 1992 A
5151978 Bronikowski et al. Sep 1992 A
5152296 Simons Oct 1992 A
5153416 Neeley Oct 1992 A
5153827 Coutre et al. Oct 1992 A
5155693 Altmayer et al. Oct 1992 A
5157595 Lovrenich Oct 1992 A
5158091 Butterfield et al. Oct 1992 A
5159673 Sackmann et al. Oct 1992 A
5160320 Yum et al. Nov 1992 A
5161211 Taguchi et al. Nov 1992 A
5167235 Seacord et al. Dec 1992 A
5169642 Brinker et al. Dec 1992 A
5172698 Stanko Dec 1992 A
5176004 Gaudet Jan 1993 A
5179569 Sawyer Jan 1993 A
5179700 Aihara et al. Jan 1993 A
5181910 Scanlon Jan 1993 A
5190185 Blechl Mar 1993 A
5190522 Wojcicki et al. Mar 1993 A
5191891 Righter Mar 1993 A
5208762 Charhut et al. May 1993 A
5208907 Shelton et al. May 1993 A
5211849 Kitaevich et al. May 1993 A
5213099 Tripp, Jr. May 1993 A
5213232 Kraft et al. May 1993 A
5213568 Lattin et al. May 1993 A
5219330 Bollish et al. Jun 1993 A
5219331 Vanderveen Jun 1993 A
5225974 Mathews et al. Jul 1993 A
5226425 Righter Jul 1993 A
5228450 Sellers Jul 1993 A
5231990 Gauglitz Aug 1993 A
5234404 Tuttle et al. Aug 1993 A
5235510 Yamada et al. Aug 1993 A
5236416 McDaniel et al. Aug 1993 A
5238001 Gallant et al. Aug 1993 A
5240007 Pytel et al. Aug 1993 A
5244463 Cordner, Jr. et al. Sep 1993 A
5245704 Weber et al. Sep 1993 A
5254096 Rondelet et al. Oct 1993 A
5256156 Kern et al. Oct 1993 A
5256157 Samiotes et al. Oct 1993 A
5261884 Stern et al. Nov 1993 A
5262943 Thibado et al. Nov 1993 A
5265010 Evans-Paganelli et al. Nov 1993 A
5265431 Gaudet et al. Nov 1993 A
5267174 Kaufman et al. Nov 1993 A
5271405 Boyer et al. Dec 1993 A
5272318 Gorman Dec 1993 A
5272321 Otsuka et al. Dec 1993 A
5273517 Barone et al. Dec 1993 A
5277188 Selker Jan 1994 A
5283861 Dangler et al. Feb 1994 A
5284150 Butterfield et al. Feb 1994 A
5286252 Tuttle et al. Feb 1994 A
5292029 Pearson Mar 1994 A
5297257 Struger et al. Mar 1994 A
5298021 Sherer Mar 1994 A
5304126 Epstein et al. Apr 1994 A
5307263 Brown Apr 1994 A
5307372 Sawyer et al. Apr 1994 A
5307463 Hyatt et al. Apr 1994 A
5311908 Barone et al. May 1994 A
5314243 McDonald et al. May 1994 A
5315505 Pratt et al. May 1994 A
5317506 Coutre et al. May 1994 A
5319363 Welch et al. Jun 1994 A
5319543 Wilhelm Jun 1994 A
5321618 Gessman Jun 1994 A
5321829 Zifferer Jun 1994 A
5324422 Colleran et al. Jun 1994 A
5325478 Shelton et al. Jun 1994 A
5327341 Whalen et al. Jul 1994 A
5331549 Crawford, Jr. Jul 1994 A
5336245 Adams et al. Aug 1994 A
5337230 Baumgartner et al. Aug 1994 A
5337747 Neftel Aug 1994 A
5337919 Spaulding et al. Aug 1994 A
5338157 Blomquist Aug 1994 A
5339421 Housel, III Aug 1994 A
5339821 Fujimoto Aug 1994 A
5341291 Roizen et al. Aug 1994 A
5341412 Ramot et al. Aug 1994 A
5348008 Bornn et al. Sep 1994 A
5348539 Herskowitz Sep 1994 A
5349675 Fitzgerald et al. Sep 1994 A
5356378 Doan Oct 1994 A
5360410 Wacks Nov 1994 A
5361202 Doue Nov 1994 A
5361758 Hall et al. Nov 1994 A
5366896 Margrey et al. Nov 1994 A
5366904 Qureshi et al. Nov 1994 A
5367555 Isoyama Nov 1994 A
5368562 Blomquist et al. Nov 1994 A
5370612 Maeda et al. Dec 1994 A
5371687 Holmes, II et al. Dec 1994 A
5374251 Smith Dec 1994 A
5374813 Shipp Dec 1994 A
5374965 Kanno Dec 1994 A
5375604 Kelly et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5377864 Blechl et al. Jan 1995 A
5378231 Johnson et al. Jan 1995 A
5379214 Arbuckle et al. Jan 1995 A
5389078 Zalesky et al. Feb 1995 A
5390238 Kirk et al. Feb 1995 A
5392951 Gardner et al. Feb 1995 A
5395320 Padda et al. Mar 1995 A
5395321 Kawahara et al. Mar 1995 A
5398336 Tantry et al. Mar 1995 A
5401059 Ferrario Mar 1995 A
5404292 Hendrickson Apr 1995 A
5404384 Colburn et al. Apr 1995 A
5406473 Yoshikura et al. Apr 1995 A
5412715 Volpe May 1995 A
5415167 Wilk May 1995 A
5416695 Stutman et al. May 1995 A
5417222 Dempsey et al. May 1995 A
5420977 Sztipanovits et al. May 1995 A
5421343 Feng Jun 1995 A
5423746 Burkett et al. Jun 1995 A
5429602 Hauser Jul 1995 A
5431201 Torchia et al. Jul 1995 A
5431299 Brewer et al. Jul 1995 A
5431627 Pastrone et al. Jul 1995 A
5433736 Nilsson Jul 1995 A
5438607 Przygoda, Jr. et al. Aug 1995 A
5440699 Farrand et al. Aug 1995 A
5441047 David et al. Aug 1995 A
5445294 Gardner et al. Aug 1995 A
5445621 Poli et al. Aug 1995 A
5446868 Gardea, II et al. Aug 1995 A
5453098 Botts et al. Sep 1995 A
5455851 Chaco et al. Oct 1995 A
5458123 Unger Oct 1995 A
5460294 Williams Oct 1995 A
5460605 Tuttle et al. Oct 1995 A
5461665 Shur et al. Oct 1995 A
5462051 Oka et al. Oct 1995 A
5464392 Epstein et al. Nov 1995 A
5465286 Clare et al. Nov 1995 A
5467773 Bergelson et al. Nov 1995 A
5468110 McDonald et al. Nov 1995 A
5469855 Pompei et al. Nov 1995 A
5471382 Tallman et al. Nov 1995 A
5474552 Palti Dec 1995 A
5482043 Zulauf Jan 1996 A
5482446 Williamson et al. Jan 1996 A
5485408 Blomquist Jan 1996 A
5490610 Pearson Feb 1996 A
5494592 Latham, Jr. et al. Feb 1996 A
5496265 Langley et al. Mar 1996 A
5496273 Pastrone et al. Mar 1996 A
5502944 Kraft et al. Apr 1996 A
5507412 Ebert et al. Apr 1996 A
5508912 Schneiderman Apr 1996 A
5509318 Gomes Apr 1996 A
5509422 Fukami Apr 1996 A
5513957 O'Leary May 1996 A
5514088 Zakko May 1996 A
5514095 Brightbill et al. May 1996 A
5515426 Yacenda et al. May 1996 A
5520450 Colson, Jr. et al. May 1996 A
5520637 Pager et al. May 1996 A
5522396 Langer et al. Jun 1996 A
5522798 Johnson et al. Jun 1996 A
5526428 Arnold Jun 1996 A
5528503 Moore et al. Jun 1996 A
5529063 Hill Jun 1996 A
5531680 Dumas et al. Jul 1996 A
5531697 Olsen et al. Jul 1996 A
5531698 Olsen Jul 1996 A
5533079 Colburn et al. Jul 1996 A
5533981 Mandro et al. Jul 1996 A
5534691 Holdaway et al. Jul 1996 A
5536084 Curtis et al. Jul 1996 A
5537313 Pirelli Jul 1996 A
5537853 Finburgh et al. Jul 1996 A
5542420 Goldman et al. Aug 1996 A
5544649 David et al. Aug 1996 A
5544651 Wilk Aug 1996 A
5544661 Davis et al. Aug 1996 A
5545140 Conero et al. Aug 1996 A
5546580 Seliger et al. Aug 1996 A
5547470 Johnson et al. Aug 1996 A
5549117 Tacklind et al. Aug 1996 A
5549460 O'Leary Aug 1996 A
5553609 Chen et al. Sep 1996 A
5558638 Evers et al. Sep 1996 A
5558640 Pfeiler et al. Sep 1996 A
5560352 Heim et al. Oct 1996 A
5562232 Pearson Oct 1996 A
5562621 Claude et al. Oct 1996 A
5563347 Martin et al. Oct 1996 A
5564434 Halperin et al. Oct 1996 A
5564803 McDonald et al. Oct 1996 A
5568912 Minami et al. Oct 1996 A
5569186 Lord et al. Oct 1996 A
5569187 Kaiser Oct 1996 A
5571258 Pearson Nov 1996 A
5573502 LeCocq et al. Nov 1996 A
5573506 Vasko Nov 1996 A
5575632 Morris et al. Nov 1996 A
5576952 Stutman et al. Nov 1996 A
5579001 Dempsey et al. Nov 1996 A
5579378 Arlinghaus, Jr. Nov 1996 A
5581369 Righter et al. Dec 1996 A
5581687 Lyle et al. Dec 1996 A
5582593 Hultman Dec 1996 A
5583758 Mcilroy et al. Dec 1996 A
5588815 Zaleski, II Dec 1996 A
5589932 Garcia-Rubio et al. Dec 1996 A
5590648 Mitchell et al. Jan 1997 A
5591344 Kenley et al. Jan 1997 A
5593267 McDonald et al. Jan 1997 A
5594637 Eisenberg et al. Jan 1997 A
5594786 Chaco et al. Jan 1997 A
5597995 Williams et al. Jan 1997 A
5598536 Slaughter, III et al. Jan 1997 A
5601445 Schipper et al. Feb 1997 A
5609575 Larson et al. Mar 1997 A
5609576 Voss et al. Mar 1997 A
5613115 Gihl et al. Mar 1997 A
5619428 Lee et al. Apr 1997 A
5619991 Sloane Apr 1997 A
5623652 Vora et al. Apr 1997 A
5623925 Swenson et al. Apr 1997 A
5626144 Tacklind et al. May 1997 A
5628619 Wilson May 1997 A
5630710 Tune et al. May 1997 A
5631844 Margrey et al. May 1997 A
5633910 Cohen May 1997 A
D380260 Hyman Jun 1997 S
5634893 Rishton Jun 1997 A
5637082 Pages et al. Jun 1997 A
5637093 Hyman et al. Jun 1997 A
5640301 Roecher et al. Jun 1997 A
5640953 Bishop et al. Jun 1997 A
5641628 Bianchi Jun 1997 A
5643193 Papillon et al. Jul 1997 A
5643212 Coutre et al. Jul 1997 A
5647853 Feldmann et al. Jul 1997 A
5647854 Olsen et al. Jul 1997 A
5651775 Walker et al. Jul 1997 A
5652566 Lambert Jul 1997 A
5658240 Urdahl et al. Aug 1997 A
5658250 Blomquist et al. Aug 1997 A
5661978 Holmes et al. Sep 1997 A
5664270 Bell et al. Sep 1997 A
5666404 Ciccotelli et al. Sep 1997 A
D385646 Chan Oct 1997 S
5678562 Sellers Oct 1997 A
5678568 Uchikubo et al. Oct 1997 A
5681285 Ford et al. Oct 1997 A
5682526 Smokoff et al. Oct 1997 A
5683367 Jordan et al. Nov 1997 A
5685844 Marttila Nov 1997 A
5687717 Halpern Nov 1997 A
5687734 Dempsey et al. Nov 1997 A
5695473 Olsen Dec 1997 A
5697951 Harpstead Dec 1997 A
5700998 Palti Dec 1997 A
5701894 Cherry et al. Dec 1997 A
5704351 Mortara et al. Jan 1998 A
5704364 Saltzstein et al. Jan 1998 A
5704366 Tacklind et al. Jan 1998 A
5712798 Langley et al. Jan 1998 A
5712912 Tomko et al. Jan 1998 A
5713485 Liff et al. Feb 1998 A
5713856 Eggers et al. Feb 1998 A
5715823 Wood et al. Feb 1998 A
5716114 Holmes et al. Feb 1998 A
5716194 Butterfield et al. Feb 1998 A
5718562 Lawless et al. Feb 1998 A
5719761 Gatti et al. Feb 1998 A
RE35743 Pearson Mar 1998 E
5724025 Tavori Mar 1998 A
5724580 Levin et al. Mar 1998 A
5732709 Tacklind et al. Mar 1998 A
5733259 Valcke et al. Mar 1998 A
5735887 Barreras, Sr. et al. Apr 1998 A
5737539 Edelson et al. Apr 1998 A
5740185 Bosse Apr 1998 A
5740800 Hendrickson et al. Apr 1998 A
5745366 Higham et al. Apr 1998 A
5745378 Barker et al. Apr 1998 A
5752917 Fuchs May 1998 A
5752976 Duffin et al. May 1998 A
5755563 Clegg et al. May 1998 A
5758095 Albaum et al. May 1998 A
5764923 Tallman et al. Jun 1998 A
5766155 Hyman et al. Jun 1998 A
5769811 Stacey et al. Jun 1998 A
5771657 Lasher et al. Jun 1998 A
5772585 Lavin et al. Jun 1998 A
5772586 Heinonen et al. Jun 1998 A
5772635 Dastur et al. Jun 1998 A
5772637 Heinzmann et al. Jun 1998 A
5776057 Swenson et al. Jul 1998 A
5778345 McCartney Jul 1998 A
5778882 Raymond et al. Jul 1998 A
5781442 Engleson et al. Jul 1998 A
5782805 Meinzer et al. Jul 1998 A
5782878 Morgan et al. Jul 1998 A
5785650 Akasaka et al. Jul 1998 A
5788669 Peterson Aug 1998 A
5788851 Kenley et al. Aug 1998 A
5790409 Fedor et al. Aug 1998 A
5791342 Woodard Aug 1998 A
5791880 Wilson Aug 1998 A
5793861 Haigh Aug 1998 A
5793969 Kamentsky et al. Aug 1998 A
5795317 Brierton et al. Aug 1998 A
5795327 Wilson et al. Aug 1998 A
5797515 Liff et al. Aug 1998 A
5800387 Duffy et al. Sep 1998 A
5801755 Echerer Sep 1998 A
5803906 Pratt et al. Sep 1998 A
5805442 Crater et al. Sep 1998 A
5805454 Valerino et al. Sep 1998 A
5805456 Higham et al. Sep 1998 A
5805505 Zheng et al. Sep 1998 A
5807321 Stoker et al. Sep 1998 A
5807322 Lindsey et al. Sep 1998 A
5807336 Russo et al. Sep 1998 A
5810747 Brudny et al. Sep 1998 A
5812410 Lion et al. Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5815566 Ramot et al. Sep 1998 A
5818528 Roth et al. Oct 1998 A
5822418 Yacenda et al. Oct 1998 A
5822544 Chaco et al. Oct 1998 A
5823949 Goltra Oct 1998 A
5826237 Macrae et al. Oct 1998 A
5829438 Gibbs et al. Nov 1998 A
5832447 Rieker et al. Nov 1998 A
5832448 Brown Nov 1998 A
5832450 Myers et al. Nov 1998 A
5833599 Schrier et al. Nov 1998 A
5835897 Dang Nov 1998 A
5836910 Duffy et al. Nov 1998 A
5841975 Layne et al. Nov 1998 A
5842841 Danby et al. Dec 1998 A
5842976 Williamson Dec 1998 A
5845253 Rensimer et al. Dec 1998 A
5848593 McGrady et al. Dec 1998 A
5851186 Wood et al. Dec 1998 A
5852590 De La Huerga Dec 1998 A
5853387 Clegg et al. Dec 1998 A
5855550 Lai et al. Jan 1999 A
5857967 Frid et al. Jan 1999 A
5859972 Subramaniam et al. Jan 1999 A
5865745 Schmitt et al. Feb 1999 A
5865786 Sibalis et al. Feb 1999 A
5867821 Ballantyne et al. Feb 1999 A
5871465 Vasko Feb 1999 A
5876926 Beecham Mar 1999 A
5880443 McDonald et al. Mar 1999 A
5882338 Gray Mar 1999 A
5883370 Walker et al. Mar 1999 A
5883576 De La Huerga Mar 1999 A
5884273 Sattizahn et al. Mar 1999 A
5884457 Ortiz et al. Mar 1999 A
5885245 Lynch et al. Mar 1999 A
5891035 Wood et al. Apr 1999 A
5891734 Gill et al. Apr 1999 A
5893697 Zimi et al. Apr 1999 A
5894273 Meador et al. Apr 1999 A
5895371 Levitas et al. Apr 1999 A
5897493 Brown Apr 1999 A
5897530 Jackson Apr 1999 A
5897989 Beecham Apr 1999 A
5899665 Makino et al. May 1999 A
5899855 Brown May 1999 A
5901150 Jhuboo et al. May 1999 A
5904668 Hyman et al. May 1999 A
5905653 Higham et al. May 1999 A
5907291 Chen et al. May 1999 A
5907493 Boyer et al. May 1999 A
5908027 Butterfield et al. Jun 1999 A
5910107 Iliff Jun 1999 A
5910252 Truitt et al. Jun 1999 A
5911132 Sloane Jun 1999 A
5911687 Sato et al. Jun 1999 A
5912818 McGrady et al. Jun 1999 A
5913197 Kameda Jun 1999 A
5913310 Brown Jun 1999 A
5915089 Stevens et al. Jun 1999 A
5915240 Karpf Jun 1999 A
5919154 Toavs et al. Jul 1999 A
5921938 Aoyama et al. Jul 1999 A
5923018 Kameda et al. Jul 1999 A
5924074 Evans Jul 1999 A
5924103 Ahmed et al. Jul 1999 A
5927540 Godlewski Jul 1999 A
5931791 Saltzstein et al. Aug 1999 A
5935060 Iliff Aug 1999 A
5935099 Peterson et al. Aug 1999 A
5935106 Olsen Aug 1999 A
5938413 Makino et al. Aug 1999 A
5939326 Chupp et al. Aug 1999 A
5939699 Perttunen et al. Aug 1999 A
5940306 Gardner et al. Aug 1999 A
5940802 Hildebrand et al. Aug 1999 A
5941829 Saltzstein et al. Aug 1999 A
5941846 Duffy et al. Aug 1999 A
5942986 Shabot et al. Aug 1999 A
5943423 Muftic Aug 1999 A
5943633 Wilson et al. Aug 1999 A
5944659 Flach et al. Aug 1999 A
5945651 Chorosinski et al. Aug 1999 A
5946083 Melendez et al. Aug 1999 A
5946659 Lancelot et al. Aug 1999 A
D414578 Chen et al. Sep 1999 S
5950006 Crater et al. Sep 1999 A
5951300 Brown Sep 1999 A
5951510 Barak Sep 1999 A
5954640 Szabo Sep 1999 A
5954885 Bollish et al. Sep 1999 A
5954971 Pages et al. Sep 1999 A
5956023 Lyle et al. Sep 1999 A
5957885 Bollish et al. Sep 1999 A
5959529 Kail, IV Sep 1999 A
5960085 de la Huerga Sep 1999 A
5960403 Brown Sep 1999 A
5960991 Ophardt Oct 1999 A
5961446 Beller et al. Oct 1999 A
5961448 Swenson et al. Oct 1999 A
5961487 Davis Oct 1999 A
5961923 Nova et al. Oct 1999 A
5963641 Crandall et al. Oct 1999 A
5964700 Tallman et al. Oct 1999 A
5966304 Cook et al. Oct 1999 A
5967975 Ridgeway Oct 1999 A
5970423 Langley et al. Oct 1999 A
5971593 McGrady Oct 1999 A
5971921 Timbel Oct 1999 A
5971948 Pages et al. Oct 1999 A
5974124 Schlueter, Jr. et al. Oct 1999 A
5975737 Crater et al. Nov 1999 A
5980490 Tsoukalis Nov 1999 A
5983193 Heinonen et al. Nov 1999 A
5987519 Peifer et al. Nov 1999 A
5991731 Colon et al. Nov 1999 A
5993046 McGrady et al. Nov 1999 A
5993420 Hyman et al. Nov 1999 A
5995077 Wilcox et al. Nov 1999 A
5995939 Berman et al. Nov 1999 A
5995965 Experton Nov 1999 A
5997167 Crater et al. Dec 1999 A
5997476 Brown Dec 1999 A
6003006 Colella et al. Dec 1999 A
6004020 Bartur Dec 1999 A
6004276 Wright et al. Dec 1999 A
6006191 DeRienzo Dec 1999 A
6006946 Williams et al. Dec 1999 A
6009333 Chaco Dec 1999 A
6010454 Arieff et al. Jan 2000 A
6011858 Stock et al. Jan 2000 A
6011999 Holmes Jan 2000 A
6012034 Hamparian et al. Jan 2000 A
6013057 Danby et al. Jan 2000 A
6014631 Teagarden et al. Jan 2000 A
6016444 John Jan 2000 A
6017318 Gauthier et al. Jan 2000 A
6018713 Coli et al. Jan 2000 A
6019745 Gray Feb 2000 A
6021392 Lester et al. Feb 2000 A
6022315 Iliff Feb 2000 A
6023522 Draganoff et al. Feb 2000 A
6024539 Blomquist Feb 2000 A
6024699 Surwit et al. Feb 2000 A
6027217 McClure et al. Feb 2000 A
6029138 Khorasani et al. Feb 2000 A
6032119 Brown et al. Feb 2000 A
6032155 de la Huerga Feb 2000 A
6033076 Braeuning et al. Mar 2000 A
6039251 Holowko et al. Mar 2000 A
6039467 Holmes Mar 2000 A
6047259 Campbell et al. Apr 2000 A
6048086 Valerino Apr 2000 A
6050940 Braun et al. Apr 2000 A
6055487 Margery et al. Apr 2000 A
6057758 Dempsey et al. May 2000 A
6059736 Tapper May 2000 A
6061603 Papadopoulos et al. May 2000 A
6065819 Holmes et al. May 2000 A
6068153 Young et al. May 2000 A
6068156 Liff et al. May 2000 A
6073046 Patel et al. Jun 2000 A
6074345 van Oostrom et al. Jun 2000 A
6079621 Vardanyan et al. Jun 2000 A
6080106 Lloyd et al. Jun 2000 A
6081048 Bergmann et al. Jun 2000 A
6081786 Barry et al. Jun 2000 A
6082776 Feinberg Jul 2000 A
6083206 Molko Jul 2000 A
6093146 Filangeri Jul 2000 A
6095985 Raymond et al. Aug 2000 A
6096561 Tayi Aug 2000 A
6098892 Peoples, Jr. Aug 2000 A
6101407 Groezinger Aug 2000 A
6101478 Brown Aug 2000 A
6102856 Groff et al. Aug 2000 A
6108399 Hernandez-Guerra et al. Aug 2000 A
6108588 McGrady Aug 2000 A
6109774 Holmes et al. Aug 2000 A
6112224 Peifer et al. Aug 2000 A
RE36871 Epstein et al. Sep 2000 E
6113554 Gilcher et al. Sep 2000 A
6116461 Broadfield et al. Sep 2000 A
6117940 Mjalli Sep 2000 A
6123524 Danby et al. Sep 2000 A
6125350 Dirbas Sep 2000 A
6129517 Danby et al. Oct 2000 A
6132371 Dempsey et al. Oct 2000 A
6134504 Douglas et al. Oct 2000 A
6135949 Russo et al. Oct 2000 A
6139177 Venkatraman et al. Oct 2000 A
6139495 De La Huerga Oct 2000 A
6141412 Smith et al. Oct 2000 A
6144922 Douglas et al. Nov 2000 A
6145695 Garrigues Nov 2000 A
6146523 Kenley et al. Nov 2000 A
6148297 Swor et al. Nov 2000 A
6149063 Reynolds et al. Nov 2000 A
6151536 Arnold et al. Nov 2000 A
6152364 Schoonen et al. Nov 2000 A
6154668 Pedersen et al. Nov 2000 A
6154726 Rensimer et al. Nov 2000 A
6157914 Seto et al. Dec 2000 A
6158965 Butterfield et al. Dec 2000 A
6160478 Jacobsen et al. Dec 2000 A
6161095 Brown Dec 2000 A
6161141 Dillon Dec 2000 A
6163737 Fedor et al. Dec 2000 A
6165154 Gray et al. Dec 2000 A
6168563 Brown Jan 2001 B1
6170007 Venkatraman et al. Jan 2001 B1
6170746 Brook et al. Jan 2001 B1
6171112 Clark et al. Jan 2001 B1
6171237 Avitall et al. Jan 2001 B1
6171264 Bader Jan 2001 B1
6173198 Schulze et al. Jan 2001 B1
6175779 Barrett Jan 2001 B1
6175977 Schumacher et al. Jan 2001 B1
6176392 William et al. Jan 2001 B1
6182047 Dirbas Jan 2001 B1
6183417 Geheb et al. Feb 2001 B1
6186145 Brown Feb 2001 B1
6192320 Margrey et al. Feb 2001 B1
6193480 Butterfield Feb 2001 B1
6195887 Danby et al. Mar 2001 B1
6198394 Jacobsen et al. Mar 2001 B1
6200264 Satherley et al. Mar 2001 B1
6200289 Hochman et al. Mar 2001 B1
6202923 Boyer et al. Mar 2001 B1
6203495 Bardy Mar 2001 B1
6203528 Deckert et al. Mar 2001 B1
6206238 Ophardt Mar 2001 B1
6206829 Iliff Mar 2001 B1
6210361 Kamen et al. Apr 2001 B1
6213391 Lewis Apr 2001 B1
6213738 Danby et al. Apr 2001 B1
6213972 Butterfield et al. Apr 2001 B1
6219439 Burger Apr 2001 B1
6219587 Ahlin et al. Apr 2001 B1
6221009 Doi et al. Apr 2001 B1
6221011 Bardy Apr 2001 B1
6221012 Maschke et al. Apr 2001 B1
6222619 Herron et al. Apr 2001 B1
6224549 Drongelen May 2001 B1
6225901 Kail, IV May 2001 B1
6226564 Stuart May 2001 B1
6226745 Wiederhold May 2001 B1
6230142 Benigno et al. May 2001 B1
6230927 Schoonen et al. May 2001 B1
6234997 Kamen et al. May 2001 B1
6245013 Minoz et al. Jun 2001 B1
6246473 Smith, Jr. et al. Jun 2001 B1
6248063 Barnhill et al. Jun 2001 B1
6248065 Brown Jun 2001 B1
6255951 De La Huerga Jul 2001 B1
6256643 Cork et al. Jul 2001 B1
6256967 Hebron et al. Jul 2001 B1
6259355 Chaco et al. Jul 2001 B1
6259654 De La Huerga Jul 2001 B1
6260021 Wong et al. Jul 2001 B1
6266645 Simpson Jul 2001 B1
6269340 Ford et al. Jul 2001 B1
D446854 Cheney, II et al. Aug 2001 S
6270455 Brown Aug 2001 B1
6270457 Bardy Aug 2001 B1
6272394 Lipps Aug 2001 B1
6272505 De La Huerga Aug 2001 B1
6277072 Bardy Aug 2001 B1
6278999 Knapp Aug 2001 B1
6283322 Liff et al. Sep 2001 B1
6283944 McMullen et al. Sep 2001 B1
6290646 Cosentino et al. Sep 2001 B1
6290650 Butterfield et al. Sep 2001 B1
6294999 Yarin et al. Sep 2001 B1
6295506 Heinonen Sep 2001 B1
6304788 Eady et al. Oct 2001 B1
6306088 Krausman et al. Oct 2001 B1
6307956 Black Oct 2001 B1
6308171 De La Huerga Oct 2001 B1
6311163 Sheehan et al. Oct 2001 B1
6312227 Davis Nov 2001 B1
6312378 Bardy Nov 2001 B1
6314384 Goetz Nov 2001 B1
6317719 Schrier et al. Nov 2001 B1
6319200 Lai et al. Nov 2001 B1
6321203 Kameda Nov 2001 B1
6322502 Schoenberg et al. Nov 2001 B1
6322504 Kirshner Nov 2001 B1
6322515 Goor et al. Nov 2001 B1
6330491 Lion Dec 2001 B1
6332090 DeFrank et al. Dec 2001 B1
RE37531 Chaco et al. Jan 2002 E
6337631 Pai et al. Jan 2002 B1
6338007 Broadfield et al. Jan 2002 B1
6339732 Phoon et al. Jan 2002 B1
6345260 Cummings, Jr. et al. Feb 2002 B1
6346886 De La Huerga Feb 2002 B1
6347553 Morris et al. Feb 2002 B1
6352200 Schoonen et al. Mar 2002 B1
6353817 Jacobs et al. Mar 2002 B1
6358225 Butterfield Mar 2002 B1
6358237 Paukovits et al. Mar 2002 B1
6361263 Dewey et al. Mar 2002 B1
6362591 Moberg Mar 2002 B1
6363282 Nichols et al. Mar 2002 B1
6363290 Lyle et al. Mar 2002 B1
6364834 Reuss et al. Apr 2002 B1
6368273 Brown Apr 2002 B1
6370841 Chudy et al. Apr 2002 B1
6381577 Brown Apr 2002 B1
6385505 Lipps May 2002 B1
6393369 Carr May 2002 B1
6397190 Goetz May 2002 B1
6401072 Haudenschild et al. Jun 2002 B1
6402702 Gilcher et al. Jun 2002 B1
6406426 Reuss et al. Jun 2002 B1
6407335 Franklin-Lees et al. Jun 2002 B1
6408330 DeLaHuerga Jun 2002 B1
6416471 Kumar et al. Jul 2002 B1
6421650 Goetz et al. Jul 2002 B1
6424996 Killcommons et al. Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6434531 Lancelot et al. Aug 2002 B1
6434569 Tomlinson et al. Aug 2002 B1
6438451 Lion Aug 2002 B1
RE37829 Charhut et al. Sep 2002 E
6449927 Hebron et al. Sep 2002 B2
6450956 Rappaport et al. Sep 2002 B1
6458102 Mann et al. Oct 2002 B1
6461037 O'Leary Oct 2002 B1
6463310 Swedlow et al. Oct 2002 B1
6468242 Wilson et al. Oct 2002 B1
6470234 McGrady Oct 2002 B1
6471089 Liff et al. Oct 2002 B2
6471645 Warkentin et al. Oct 2002 B1
6471646 Thede Oct 2002 B1
6475146 Frelburger et al. Nov 2002 B1
6475148 Jackson et al. Nov 2002 B1
6475180 Peterson et al. Nov 2002 B2
6478737 Bardy Nov 2002 B2
6485465 Moberg et al. Nov 2002 B2
6494831 Koritzinsky Dec 2002 B1
6511138 Gardner et al. Jan 2003 B1
6519569 White et al. Feb 2003 B1
6537244 Paukovits Mar 2003 B2
6542902 Dulong et al. Apr 2003 B2
6542910 Cork et al. Apr 2003 B2
6544174 West et al. Apr 2003 B2
6544228 Heitmeier Apr 2003 B1
6551243 Bocionek et al. Apr 2003 B2
6551276 Mann et al. Apr 2003 B1
6554791 Cartledge et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6555986 Moberg Apr 2003 B2
6558321 Burd et al. May 2003 B1
6561975 Pool et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564104 Nelson et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6564121 Wallace et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6575900 Zweig et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579232 Sakamaki et al. Jun 2003 B2
6581069 Robinson et al. Jun 2003 B1
6581798 Liff et al. Jun 2003 B2
6584336 Ali et al. Jun 2003 B1
6585157 Brandt et al. Jul 2003 B2
6585644 Lebel et al. Jul 2003 B2
6585675 O'Mahony et al. Jul 2003 B1
6592551 Cobb Jul 2003 B1
6593528 Franklin-Lees et al. Jul 2003 B2
6602469 Maus et al. Aug 2003 B1
6607485 Bardy Aug 2003 B2
6610973 Davis, III Aug 2003 B1
6613009 Bainbridge et al. Sep 2003 B1
6616633 Butterfield et al. Sep 2003 B1
6635014 Starkweather et al. Oct 2003 B2
6648821 Lebel et al. Nov 2003 B2
6659948 Lebel et al. Dec 2003 B2
6664893 Eveland et al. Dec 2003 B1
6668196 Villegas et al. Dec 2003 B1
6669663 Thompson Dec 2003 B1
6673314 Burbank et al. Jan 2004 B1
6687546 Lebel et al. Jan 2004 B2
6689091 Bui et al. Feb 2004 B2
6694191 Starkweather et al. Feb 2004 B2
6694334 DuLong et al. Feb 2004 B2
6711460 Reese Mar 2004 B1
6731324 Levy May 2004 B2
6733447 Lai et al. May 2004 B2
6735497 Wallace et al. May 2004 B2
6740075 Lebel et al. May 2004 B2
6746398 Hervy et al. Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6768425 Flaherty et al. Jul 2004 B2
6771369 Rzasa et al. Aug 2004 B2
6775602 Gordon, Jr. et al. Aug 2004 B2
6776304 Liff et al. Aug 2004 B2
6790198 White et al. Sep 2004 B1
6804656 Rosenfeld et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6811707 Rovatti et al. Nov 2004 B2
6813473 Bruker Nov 2004 B1
6813519 Lebel et al. Nov 2004 B2
6814255 Liff et al. Nov 2004 B2
6820093 De La Huerga Nov 2004 B2
6842736 Brzozowski Jan 2005 B1
6847861 Lunak et al. Jan 2005 B2
6854088 Massengale et al. Feb 2005 B2
6871211 Labounty et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6877530 Osborne et al. Apr 2005 B2
6880034 Manke et al. Apr 2005 B2
6885288 Pincus Apr 2005 B2
6887201 Bardy May 2005 B2
6892941 Rosenblum May 2005 B2
6912549 Rotter et al. Jun 2005 B2
6913590 Sorenson et al. Jul 2005 B2
6915265 Johnson Jul 2005 B1
6915823 Osborne et al. Jul 2005 B2
6928452 De La Huerga Aug 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6974437 Lebel et al. Dec 2005 B2
6975924 Kircher et al. Dec 2005 B2
6976628 Krupa Dec 2005 B2
6979306 Moll Dec 2005 B2
6980958 Surwit et al. Dec 2005 B1
6981644 Cheong et al. Jan 2006 B2
6985870 Martucci et al. Jan 2006 B2
6991002 Osborne et al. Jan 2006 B2
6995664 Darling Feb 2006 B1
7006893 Hart et al. Feb 2006 B2
7015806 Naidoo et al. Mar 2006 B2
7017622 Osborne et al. Mar 2006 B2
7017623 Tribble et al. Mar 2006 B2
7028723 Alouani et al. Apr 2006 B1
7096212 Tribble et al. Aug 2006 B2
7117902 Osborne Oct 2006 B2
7151982 Liff et al. Dec 2006 B2
7194336 DiGianfilippo et al. Mar 2007 B2
7209891 Addy et al. Apr 2007 B1
7240699 Osborne et al. Jul 2007 B2
7255680 Gharib Aug 2007 B1
7277579 Huang Oct 2007 B2
7277757 Casavant et al. Oct 2007 B2
7317967 DiGianfilippo et al. Jan 2008 B2
7321861 Oon Jan 2008 B1
7343224 DiGianfilippo et al. Mar 2008 B2
7403901 Carley et al. Jul 2008 B1
7427002 Liff et al. Sep 2008 B2
7493263 Helmus et al. Feb 2009 B2
7499581 Tribble Mar 2009 B2
7509280 Haudenschild Mar 2009 B1
7555557 Bradley et al. Jun 2009 B2
7561312 Proudfoot et al. Jul 2009 B1
7581953 Lehmann et al. Sep 2009 B2
7599516 Limer Oct 2009 B2
7610115 Rob et al. Oct 2009 B2
7630908 Amrien et al. Dec 2009 B1
7636718 Steen et al. Dec 2009 B1
7672859 Louie et al. Mar 2010 B1
7698019 Moncrief et al. Apr 2010 B2
7698154 Marchosky Apr 2010 B2
7734478 Goodall et al. Jun 2010 B2
7753085 Tribble et al. Jul 2010 B2
7769601 Bleser et al. Aug 2010 B1
7783383 Eliuk et al. Aug 2010 B2
D624225 Federico et al. Sep 2010 S
7801642 Ansari et al. Sep 2010 B2
7847970 McGrady Dec 2010 B1
7853621 Guo Dec 2010 B2
7904822 Monteleone et al. Mar 2011 B2
7931859 Mlodzinski et al. Apr 2011 B2
7937290 Bahir May 2011 B2
7986369 Burns Jul 2011 B1
7991507 Liff et al. Aug 2011 B2
8170271 Chen May 2012 B2
8191339 Tribble Jun 2012 B2
8215557 Reno et al. Jul 2012 B1
8220503 Tribble Jul 2012 B2
8225824 Eliuk et al. Jul 2012 B2
D667961 Marmier Sep 2012 S
8267129 Doherty et al. Sep 2012 B2
8271138 Eliuk et al. Sep 2012 B2
8280549 Liff et al. Oct 2012 B2
8284305 Newcomb et al. Oct 2012 B2
8374887 Alexander Feb 2013 B1
8386070 Eliuk et al. Feb 2013 B2
8548824 daCosta Oct 2013 B1
8554579 Tribble et al. Oct 2013 B2
D693480 Spiess et al. Nov 2013 S
8595206 Ansari Nov 2013 B1
8666541 Ansari et al. Mar 2014 B1
8678047 Tribble et al. Mar 2014 B2
D715958 Bossart et al. Oct 2014 S
9053218 Osborne et al. Jun 2015 B2
D733480 Shao Jul 2015 S
D738152 Grasselli et al. Sep 2015 S
D753428 Shao Apr 2016 S
9362969 Burgess et al. Jun 2016 B1
9382021 Tribble et al. Jul 2016 B2
9662273 Ranalletta et al. May 2017 B2
9930297 Alexander et al. Mar 2018 B2
9956145 Thompson et al. May 2018 B2
20010001237 Stroda et al. May 2001 A1
20010003177 Schena et al. Jun 2001 A1
20010007053 Bardy Jul 2001 A1
20010007932 Kamen et al. Jul 2001 A1
20010011153 Bardy Aug 2001 A1
20010016699 Burbank et al. Aug 2001 A1
20010017817 De La Huerga Aug 2001 A1
20010021801 Bardy Sep 2001 A1
20010025138 Bardy Sep 2001 A1
20010025156 Bui et al. Sep 2001 A1
20010027634 Hebron et al. Oct 2001 A1
20010028308 De La Huerga Oct 2001 A1
20010030234 Wiklof Oct 2001 A1
20010031944 Peterson et al. Oct 2001 A1
20010032101 Statius Muller Oct 2001 A1
20010034502 Moberg et al. Oct 2001 A1
20010034614 Fletcher-Haynes et al. Oct 2001 A1
20010034616 Giannini Oct 2001 A1
20010037057 Bardy Nov 2001 A1
20010037083 Hartlaub et al. Nov 2001 A1
20010037217 Abensour et al. Nov 2001 A1
20010037220 Merry et al. Nov 2001 A1
20010041920 Starkweather et al. Nov 2001 A1
20010044588 Mault Nov 2001 A1
20010044731 Coffman et al. Nov 2001 A1
20010047125 Quy Nov 2001 A1
20010051764 Bardy Dec 2001 A1
20010053885 Gielen et al. Dec 2001 A1
20020002326 Causey, III et al. Jan 2002 A1
20020002473 Schrier et al. Jan 2002 A1
20020004645 Carlisle et al. Jan 2002 A1
20020007285 Rappaport Jan 2002 A1
20020010568 Rubbert et al. Jan 2002 A1
20020010679 Felsher Jan 2002 A1
20020013612 Whitehurst Jan 2002 A1
20020016567 Hochman et al. Feb 2002 A1
20020016568 Lebel et al. Feb 2002 A1
20020016719 Nemeth et al. Feb 2002 A1
20020016722 Kameda Feb 2002 A1
20020019606 Lebel et al. Feb 2002 A1
20020019748 Brown Feb 2002 A1
20020022776 Bardy Feb 2002 A1
20020025796 Taylor et al. Feb 2002 A1
20020026104 Bardy Feb 2002 A1
20020029157 Marchosky Mar 2002 A1
20020029776 Blomquist Mar 2002 A1
20020032582 Feeney et al. Mar 2002 A1
20020032602 Lanzillo, Jr. et al. Mar 2002 A1
20020038392 De La Huerga Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020044043 Chaco et al. Apr 2002 A1
20020046062 Kameda Apr 2002 A1
20020046185 Villart et al. Apr 2002 A1
20020046346 Evans Apr 2002 A1
20020052539 Haller et al. May 2002 A1
20020052542 Bardy May 2002 A1
20020052574 Hochman et al. May 2002 A1
20020062227 Yuyama May 2002 A1
20020062229 Alban et al. May 2002 A1
20020065540 Lebel et al. May 2002 A1
20020065686 Monteleone et al. May 2002 A1
20020067273 Jaques et al. Jun 2002 A1
20020072733 Flaherty Jun 2002 A1
20020073250 Ommering Jun 2002 A1
20020077852 Ford et al. Jun 2002 A1
20020077865 Sullivan Jun 2002 A1
20020082480 Riff et al. Jun 2002 A1
20020082865 Bianco et al. Jun 2002 A1
20020082868 Pories et al. Jun 2002 A1
20020084904 De La Huerga Jul 2002 A1
20020087120 Rogers et al. Jul 2002 A1
20020091309 Auer Jul 2002 A1
20020099283 Christ et al. Jul 2002 A1
20020099301 Bardy Jul 2002 A1
20020100762 Liff et al. Aug 2002 A1
20020107476 Mann et al. Aug 2002 A1
20020107707 Naparstek et al. Aug 2002 A1
20020116226 Auer et al. Aug 2002 A1
20020116509 De La Huerga Aug 2002 A1
20020128606 Cowan et al. Sep 2002 A1
20020128871 Adamson et al. Sep 2002 A1
20020128880 Kunikiyo Sep 2002 A1
20020133377 Brown Sep 2002 A1
20020140675 Ali et al. Oct 2002 A1
20020143254 Maruyama Oct 2002 A1
20020156462 Stultz Oct 2002 A1
20020158128 Ashiuro Oct 2002 A1
20020165491 Reilly Nov 2002 A1
20020169636 Eggers et al. Nov 2002 A1
20020173875 Wallace et al. Nov 2002 A1
20020188467 Eke Dec 2002 A1
20020198473 Kumar et al. Dec 2002 A1
20020198513 Lebel et al. Dec 2002 A1
20020198624 Greenwald Dec 2002 A1
20030006878 Chung Jan 2003 A1
20030023177 Bardy Jan 2003 A1
20030033532 Marks Feb 2003 A1
20030036783 Bauhahn et al. Feb 2003 A1
20030046114 Davies et al. Mar 2003 A1
20030046280 Rotter et al. Mar 2003 A1
20030046439 Manke et al. Mar 2003 A1
20030050621 Lebel et al. Mar 2003 A1
20030050731 Rosenblum Mar 2003 A1
20030052787 Zerhusen Mar 2003 A1
20030060753 Starkweather et al. Mar 2003 A1
20030060754 Reilly Mar 2003 A1
20030060765 Campbell et al. Mar 2003 A1
20030060768 Kiyatake Mar 2003 A1
20030065287 Spohn et al. Apr 2003 A1
20030076736 Buker et al. Apr 2003 A1
20030078534 Hochman et al. Apr 2003 A1
20030079746 Hickle May 2003 A1
20030083901 Bosch et al. May 2003 A1
20030088238 Poulsen et al. May 2003 A1
20030097092 Flaherty May 2003 A1
20030114836 Estes et al. Jun 2003 A1
20030117580 Franz et al. Jun 2003 A1
20030125609 Becker Jul 2003 A1
20030125611 Bardy Jul 2003 A1
20030139701 White et al. Jul 2003 A1
20030144878 Wilkes et al. Jul 2003 A1
20030149599 Goodall et al. Aug 2003 A1
20030154108 Fletcher-Haynes et al. Aug 2003 A1
20030158508 DiGianfilippo Aug 2003 A1
20030160683 Blomquist Aug 2003 A1
20030163088 Blomquist Aug 2003 A1
20030163223 Blomquist Aug 2003 A1
20030163789 Blomquist Aug 2003 A1
20030167035 Flaherty et al. Sep 2003 A1
20030176933 Lebel et al. Sep 2003 A1
20030179287 Kozic et al. Sep 2003 A1
20030181851 Mann et al. Sep 2003 A1
20030182164 Blomquist Sep 2003 A1
20030195397 Bardy Oct 2003 A1
20030200117 Manetta et al. Oct 2003 A1
20030201697 Richardson Oct 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030225596 Richardson et al. Dec 2003 A1
20030225728 Moura Dec 2003 A1
20030231803 Huang Dec 2003 A1
20040002874 Shaffer et al. Jan 2004 A1
20040017475 Akers et al. Jan 2004 A1
20040019607 Moubayed et al. Jan 2004 A1
20040115132 Brown Jan 2004 A1
20040039260 Bardy Feb 2004 A1
20040039264 Bardy Feb 2004 A1
20040051368 Caputo et al. Mar 2004 A1
20040055611 Penny et al. Mar 2004 A1
20040064343 Korpman et al. Apr 2004 A1
20040073329 Engleson Apr 2004 A1
20040088187 Chudy et al. May 2004 A1
20040088374 Webb et al. May 2004 A1
20040111293 Firanek et al. Jun 2004 A1
20040116862 Ray Jun 2004 A1
20040117215 Marchosky Jun 2004 A1
20040128162 Schlotterbeck et al. Jul 2004 A1
20040129616 Mori et al. Jul 2004 A1
20040148195 Kalies Jul 2004 A1
20040158193 Bui et al. Aug 2004 A1
20040172283 Vanderveen et al. Sep 2004 A1
20040172289 Kozic et al. Sep 2004 A1
20040172300 Mihai et al. Sep 2004 A1
20040193328 Zaitsu et al. Sep 2004 A1
20040193453 Butterfield et al. Sep 2004 A1
20040204673 Flaherty Oct 2004 A1
20040204954 Lacko Oct 2004 A1
20040215490 Duchon et al. Oct 2004 A1
20040220829 Baharav et al. Nov 2004 A1
20040225528 Brock Nov 2004 A1
20040235446 Flaherty et al. Nov 2004 A1
20040236630 Kost et al. Nov 2004 A1
20040248295 Katsuhiko et al. Dec 2004 A1
20040260233 Garibotto et al. Dec 2004 A1
20040260577 Dahlin et al. Dec 2004 A1
20050001033 Cheong et al. Jan 2005 A1
20050017864 Tsoukalis Jan 2005 A1
20050033124 Kelly et al. Feb 2005 A1
20050033773 Roberge et al. Feb 2005 A1
20050038680 McMahon Feb 2005 A1
20050039742 Hickle Feb 2005 A1
20050043665 Vinci et al. Feb 2005 A1
20050045548 Brugger et al. Mar 2005 A1
20050054923 Pan Mar 2005 A1
20050060372 DeBettencourt et al. Mar 2005 A1
20050080651 Morrison et al. Apr 2005 A1
20050187794 Kimak Aug 2005 A1
20050209737 Kircher Sep 2005 A1
20050228238 Monitzer Oct 2005 A1
20050279419 Tribble et al. Dec 2005 A1
20060084042 Weaver et al. Apr 2006 A1
20060124656 Popovich, Jr. Jun 2006 A1
20060136095 Rob et al. Jun 2006 A1
20060149416 Mohapatra et al. Jul 2006 A1
20060161294 DiMaggio Jul 2006 A1
20060173714 Grotzinger, Jr. Aug 2006 A1
20060178578 Tribble et al. Aug 2006 A1
20060181391 McNeill et al. Aug 2006 A1
20060235881 Masarie et al. Oct 2006 A1
20060259195 Eliuk Nov 2006 A1
20070043767 Osborne et al. Feb 2007 A1
20070047980 Limer et al. Mar 2007 A1
20070088568 Goodall et al. Apr 2007 A1
20070110305 Corcoran et al. May 2007 A1
20070125442 Tribble et al. Jun 2007 A1
20070168228 Lawless Jul 2007 A1
20070179806 Knowlton et al. Aug 2007 A1
20070189597 Limer et al. Aug 2007 A1
20070192139 Cookson et al. Aug 2007 A1
20070216998 Sander Sep 2007 A1
20070239482 Finn et al. Oct 2007 A1
20070239997 Qu et al. Oct 2007 A1
20080046292 Myers et al. Feb 2008 A1
20080056556 Eller et al. Mar 2008 A1
20080059228 Bossi et al. Mar 2008 A1
20080091467 Moncrief et al. Apr 2008 A1
20080119958 Bear et al. May 2008 A1
20080125897 DiGianfilippo et al. May 2008 A1
20080147554 Stevens et al. Jun 2008 A1
20080195246 Tribble et al. Aug 2008 A1
20080306926 Friedlander et al. Dec 2008 A1
20090024414 Mansour et al. Jan 2009 A1
20090080408 Natoli et al. Mar 2009 A1
20090097368 Vlutters et al. Apr 2009 A1
20090138340 Borr et al. May 2009 A1
20090188937 Kim Jul 2009 A1
20090205877 Claypool Aug 2009 A1
20090210252 Silver Aug 2009 A1
20090235194 Arndt et al. Sep 2009 A1
20090258331 Do et al. Oct 2009 A1
20090285762 Flower Nov 2009 A1
20090313044 Haque et al. Dec 2009 A1
20090323170 Lin Dec 2009 A1
20090324032 Chen Dec 2009 A1
20100017031 Rob et al. Jan 2010 A1
20100091281 Suzuki Apr 2010 A1
20100094653 Tribble Apr 2010 A1
20100128165 Newcomb et al. May 2010 A1
20100157293 Rzasa et al. Jun 2010 A9
20100185456 Kansal Jul 2010 A1
20100241270 Eliuk et al. Sep 2010 A1
20110119088 Gunn May 2011 A1
20110191121 Fioravanti Aug 2011 A1
20110202366 Akers et al. Aug 2011 A1
20110208350 Eliuk et al. Aug 2011 A1
20110267465 Alexander et al. Nov 2011 A1
20120083666 Waugh Apr 2012 A1
20120097290 Mikhaeil Apr 2012 A1
20120200596 Gotou et al. Aug 2012 A1
20120211565 Colavito et al. Aug 2012 A1
20120241043 Perazzo Sep 2012 A1
20120303388 Suresh-Kumar Benkata Vishnubhalta et al. Nov 2012 A1
20130079581 Agamaite Mar 2013 A1
20130090947 Nockley Apr 2013 A1
20130197445 Schabbach Aug 2013 A1
20130262138 Jaskela et al. Oct 2013 A1
20130279774 Helgason et al. Oct 2013 A1
20130304510 Chan et al. Nov 2013 A1
20130314535 Yuyama et al. Nov 2013 A1
20130342676 Amano Dec 2013 A1
20140022569 Matsui et al. Jan 2014 A1
20140156064 Crawford et al. Jun 2014 A1
20140156294 Tribble et al. Jun 2014 A1
20140214436 Utech et al. Jul 2014 A1
20140350950 Jaskela et al. Nov 2014 A1
20150205932 Tribble Jul 2015 A1
20150227719 Ranalletta Aug 2015 A1
20150272320 Ranalletta et al. Oct 2015 A1
20150278477 Tribble Oct 2015 A1
20150286799 Padmani Oct 2015 A1
20160072985 Sandmann et al. Mar 2016 A1
20160092638 Padmani Mar 2016 A1
20160092639 Padmani Mar 2016 A1
20160140315 Diaz et al. May 2016 A1
20160210437 Padmani et al. Jul 2016 A1
20160371462 Wallen Dec 2016 A1
20170372034 Tribble Dec 2017 A1
Foreign Referenced Citations (96)
Number Date Country
1516257 May 1999 CN
2440518 Aug 2001 CN
1131076 Dec 2003 CN
0237588 Sep 1987 EP
0462466 Dec 1991 EP
0505627 Sep 1992 EP
0522527 Jan 1993 EP
0439355 Sep 1994 EP
0844581 May 1998 EP
0960627 Dec 1999 EP
0970655 Jan 2000 EP
1072994 Feb 2001 EP
1107158 Jun 2001 EP
1097671 Feb 2003 EP
994977 Jun 1965 GB
2210713 Feb 1987 GB
2279784 Jan 1995 GB
2285135 Jun 1995 GB
2379037 Feb 2003 GB
53137644 Dec 1978 JP
61066950 Apr 1986 JP
63068133 Mar 1988 JP
2111375 Apr 1990 JP
3423055 Jan 1994 JP
6086813 Mar 1994 JP
06327636 Nov 1994 JP
07204253 Aug 1995 JP
104585 Jan 1998 JP
10014890 Jan 1998 JP
10079770 Mar 1998 JP
2000036032 Feb 2000 JP
03055131 Apr 2000 JP
2002011095 Jan 2002 JP
2002092181 Mar 2002 JP
2002520718 Jul 2002 JP
2003022322 Jan 2003 JP
2004078970 Mar 2004 JP
2004326436 Nov 2004 JP
2004340770 Dec 2004 JP
2005252710 Sep 2005 JP
2006033291 Feb 2006 JP
2006334062 Dec 2006 JP
2007198934 Aug 2007 JP
2008139201 Jun 2008 JP
4276654 Jun 2009 JP
2009265827 Nov 2009 JP
2010056619 Mar 2010 JP
2010170504 Aug 2010 JP
2010533927 Oct 2010 JP
2011151430 Aug 2011 JP
2012078265 Apr 2012 JP
5342197 Nov 2013 JP
5747150 Jul 2015 JP
6086813 Mar 2017 JP
20000036642 Jul 2000 KR
1020000036642 Jul 2000 KR
20010094703 Nov 2001 KR
1020010094703 Nov 2001 KR
20050054379 Dec 2003 KR
20110115927 Oct 2011 KR
1020110115927 Oct 2011 KR
20130001500 Jan 2013 KR
WO8400493 Feb 1984 WO
WO9524010 Sep 1995 WO
WO9634291 Oct 1996 WO
WO9741525 Nov 1997 WO
WO9814275 Apr 1998 WO
WO9815092 Apr 1998 WO
WO9824358 Jun 1998 WO
WO9833433 Aug 1998 WO
WO9859487 Dec 1998 WO
WO9904043 Jan 1999 WO
WO9910029 Mar 1999 WO
WO9942933 Aug 1999 WO
WO9944162 Sep 1999 WO
WO9959472 Nov 1999 WO
WO0013588 Mar 2000 WO
WO0029983 May 2000 WO
WO0043941 Jul 2000 WO
WO0052437 Sep 2000 WO
WO0052626 Sep 2000 WO
WO0057339 Sep 2000 WO
WO0060449 Oct 2000 WO
WO0069331 Nov 2000 WO
WO0072181 Nov 2000 WO
WO0078374 Dec 2000 WO
WO0101305 Jan 2001 WO
WO0102979 Jan 2001 WO
WO0106468 Jan 2001 WO
WO0145774 Jun 2001 WO
WO0217777 Jul 2002 WO
WO02091276 Nov 2002 WO
WO03025826 Mar 2003 WO
WO03094073 Nov 2003 WO
WO2004070557 Aug 2004 WO
WO2004070994 Aug 2004 WO
Non-Patent Literature Citations (174)
Entry
AHRQ Health Information Technology Program—Update Jun. 2005 Fact Sheet,, http://www.ahrq.gov/research/findings/factsheets/it/hitfact/index.html—3 pages.
Albert A. Cook, “An integrated nursing-pharmacy approach to a computerized medication dispensing/administration system,” Hospital Pharmacy, May 1985, pp. 321-325, vol. 20, JB Lippincott Company, Philadelphia, PA.
Allan T. Pryor, “Current State of Computer-based Patient Record Systems,” Aspects of the Computer-based Patient Record, 1992, pp. 67-82, Springer-Verlag, New York, NY.
Anderson, Howard “A Narrative on the History of the Development of Telepharmacy in North Dakota from the Board of Pharmacy's Perspective Recorded by Excerpts from Board Minutes”, Feb. 2006.
Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999, pp. 1404-1405.
Ann Slone Endo, “Using Computers in Newborn Intensive Care Settings,” American Journal of Nursing, Jul. 1981, pp. 1336-1337.
Anonymous, “Chains covet customized pharmacy integration” Drug Store New, Aug. 18, 2003, vol. 25, No. 10—p. 73.
Automated Dispensing Technologies: Directory of Vendors, http://pharmacyautomation.com/vendors.html, Jun. 5, 2003—3 pages.
Auto Syringe® AS40A Infusion Pump Technical Manual, 1995, 89 pages, Baxter Healthcare Corporation, Deerfield, IL.
Auto Syringe® AS40A: Model AS40A Infusion Pump Operation Manual, undated, 78 pages, Baxter Healthcare Corporation, Deerfield, IL.
Baxa Corporation, DoseEdge The Leading Edge in Dose Management, Brochure, published copyright date 2010—5 pages.
Baxa Corporation, Product Catalog 2010-2011, published at least by Sep. 15, 2012, https://web.archive.org/web/20120915210739http://www.baxa.com/resources/docs/BaxaCatalog.pdf (52 pages).
Bell Atlantic Healthcare Systems, Inc., court exhibit, StatLan Functions and Features, Specification, release 3.5, dated Nov. 12, 1992, 49 pages.
Ben Schneiderman, “Designing the User Interface: Strategies for Effective Human-Computer Interaction,” 2d Ed., 1992, Chapter 5: Direct Manipulation (56 pages), Addison-Wesley Publishing Company.
“Block Medical: Growing with Home Infusion Therapy,” taken from Invivo, The Business and Medicine Report, Apr. 1991, pp. 7-9.
Bynum et al., “The Effect of Telepharmacy Counseling on Metered-Dose Inhaler Technique among Adolescents with Asthma in Rural Arkansas”, Telemedicine Journal and e-health, vol. 7, No. 3, 2001, Mary AnnLiebert, Inc., pp. 207-218.
Cabral, Jr. et al., “Multmedia Systems for Telemedicine Systems for Telemedicine and Their Communications Requirements,” IEEE Communications Magazine Jul. 1996, pp. 20-27.
Cardinal Health Introduces Rxe-source(SM) to Address Pharmacist Labor Shortage and Medication Safety Challenges at Hospitals. PR Newswire, Feb. 25, 2003—5 pages.
Casey, Michelle M. et al., “Pharmacist Staffing and the Use of Technology in Small Rural Hospitals: Implications for Medication Safety” Upper Midwest Rural Health Research Center, Dec. 2005—51 pages.
Cato Reference Manual, Support for Trial Version (Abridged), Vienna, May 2004 Jun. 1, 2004.
Cato Reference Manual, Vienna, May 2005 May 1, 2005.
Charles Safran, M.D. et al., “Computer-Based Support for Clinical Decision Making,” Clinical Computin, vol. 7, No. 5 (1990), pp. 319-322.
Clayton M. Curtis, “A Computer-based Patient Record Emerging from the Public Sector: The Decentralized Hospital Computer Program,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 75-132, Computer-based Patient Record Institute, Inc., Bethesda, MD.
Clement J. McDonald, M.D. et al, “The Three-Legged Stool: Regenstrief Institute for Health Care,” Third Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1997, pp. 131-158, Computer-based Patient Record Institute, Inc., Bethesda, MD.
Clement J. McDonald, M.D. et al., The Regenstrief Medical Record System: 20 Years of Experience in Hospitals, Clinics, and Neighborhood Health Centers,: M.D. Computing, 1992 pp. 206-217, vol. 9, No. 4, Springer-Verlag, New York, NY.
Clifton, G. Dennis et al., “Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing” Am J Health-Syst Pharm, vol. 60, Dec. 15, 2003 oe pp. 2577-2582.
Dan Murphy, “Nuclear Pharmacy Primer”, Radiation Protection Management, vol. 20, No. 5 (2003), pp. 1-10.
Dan Scheraga; “Tech firms answer chain pharmacy's call for productivity,” Drug Store News; Dec. 15, 2003; 25, 17; ProQuest Research Library, p. 31-32.
Daniel Andresen et al., “Scalability Issues for High Performance Digital Libraries on the World Wide Web,” Proceedings of ADL '96, 1996, pp. 139-148, IEEE.
Daniel J. Nigrin et al., “Glucoweb: A Case Study of Secure, Remote Biomonitoring and Communication,” Proceedings of the 2000, 5 pages, American Medical Informatics Association, Bethesda, MD.
Darryl V. Wareham et al., “Combination Medication Cart and Computer Terminal in Decentralized Drug Distribution,” American Journal of Hospital Pharmacy, Jun. 1983, pp. 976-978, vol. 40, American Society of Hospital Pharmacists.
Dart, Luann, “Digital Doses” Rural Electric, Jan. 2005—pp. 28-31.
Deborah J. Mayhew, “Principles and Guidelines in Software user Interface Designs,” 1992, selected portions of Chapter 9, 17 pages, Prentice-Hall, Inc.
Defendants Initial Invalidity Contentions with Exhibits A and B dated Sep. 8, 2014; Civil Action No. 1:14-cv-00222.
Dennis D. Cote et al., “Robotic system for i.v. antineoplastic drug preparation: Description and preliminary evaluation under simulated conditions,” American Journal of Hospital Pharmacy, Nov. 1989, pp. 2286-2293, vol. 46, American Society of Hospital Pharmacists.
Donna Young; “Loan repayments help pharmacists provide care in medically underserved areas,” American Journal of Health-System Pharmacy; Nov. 1, 2003, pp. 2186-2188, vol. 60.
Environmental Scan of Pharmacy Technicians; M. MacInnis; Canadian Pharmacists Association; Sep. 2001.
Exhibit 1, Publications Manually Reviewed for the Search to U.S. Pat. No. 8,347,887 titled “System and Method for Remotely Supervising and Verifying Pharmacy Functions” As of Jun. 25, 2014.
Exhibit 1001 U.S. Pat. No. 8,374,887, Alexander issued Feb. 12, 2013.
Exhibit 1002 Patent File History U.S. Pat. No. 8,374,887.
Exhibit 1003, Declaration of Mr. Brian T. Hart from U.S. Pat. No. 8,374,887.
Exhibit 1004, Declaration of Wayne H. Grant from U.S. Pat. No. 8,374,887.
Exhibit 1005, 22 TAC §§291.20, 291.36, and 291.71-291.74 date issued Mar. 5, 2015 from U.S. Pat. No. 8,374,887.
Exhibit 1006 U.S. Pat. No. 6,711,460 Reese issued Mar. 23, 2004 from U.S. Pat. No. 8,374,887.
Exhibit 1009, Peterson et al., The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities; the journal of Pharmacy Technology, vol. 20, No. 1, Jan./Feb. 2004—pp. 1-39 from U.S. Pat. No. 8,374,887.
Exhibit 1010, Declaration of Benjamin E. Weed from U.S. Pat. No. 8,374,887.
Exhibit 1011, Complaint—Alexander v. Baxter, (W.D.Texas 2014) filed Mar. 13, 2014 from U.S. Pat. No. 8,374,887.
Exhibit 1012, Charles F. Seifert et al., “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education, 2004; 68 (3) Article 60—pp. 1-9 from U.S. Pat. No. 8,374,887.
Exhibit 1013, Assignment Emily H. Alexander to Becton, Dickinson and Company; U.S. Appl. No. 13/747,231; Reel 034110/Frame 0789 from U.S. Pat. No. 8,374,887.
Exhibit 1014, Exhibit A—Corrected Parties' Claims Construction Terms, Proposed Construction and cites Civil, 1:14cv-00222-LY—pp. 1-7 from U.S. Pat. No. 8,374,887.
Exhibit 1015, Information about Telepharmacy presentation 42503 and Presentation Telepharmacy at Texas Tech; Jon Phillips—1-27 from U.S. Pat. No. 8,374,887.
Exhibit 1017, Declaration of Dr. Roger W. Anderson in Support of Becton, Dickinson & Company's Response to Baxter's Motion for Summary Judgment of Invalidity Based Upon 35 U.S.C. § 101 filed Jan. 15, 2015 from U.S. Pat. No. 8,374,887.
Exhibit 1018, Plaintiff's Claim Construction Brief, 1:14-cv-222-LY filed Oct. 17, 2014 from U.S. Pat. No. 8,374,887.
Exhibit 1019, Plaintiff's Reply Claim Construction Brief, 1:14-cv-222-LY filed Nov. 7, 2014 from U.S. Pat. No. 8,374,887.
Exhibit 1020, The United States Pharmacopeia—the Official Compendia of Standards; 2004 from U.S. Pat. No. 8,374,887.
Exhibit 1021, Curriculum Vitae of Brian T Hart from U.S. Pat. No. 8,374,887.
Exhibit 1022, Curriculum Vitae of Wayne H Grant—Expert oversight—Expert Witness—Litigation Support from U.S. Pat. No. 8,374,887.
Exhibit 1023, Charles D Peterson et al., “The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities,” J Pharm Technol, 2004; vol. 20—pp. 028-039 from U.S. Pat. No. 8,374,887.
Exhibit 1025, Affidavit of Christopher Butler with attached Telemedicine Report Archive dated Mar. 4, 2015—6 pages from U.S. Pat. No. 8,374,887.
Exhibit 1026, Affidavit of Christopher Butler with attached presentation Telepharmacy at Text Tech—Jon Phillips dated Mar. 4, 2015—31 pages from U.S. Pat. No. 8,374,887.
Exhibit 1027, Order on Motion for Summary Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887.
Exhibit 1028, Final Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887.
Exhibit 1029 Charles Seifert from U.S. Pat. No. 8,374,887.
Exhibit 1030 Deposition of Charles Seifert Dec. 4, 2015 from U.S. Pat. No. 8,374,887.
Exhibit 1031 Deposition of Diane B. Ginsburg, PhD. Dec. 16, 2015 from U.S. Pat. No. 8,374,887.
Exhibit 1032 Texas Administrative Code, Title 22, Chapter 291, Subchapter A, Section 291.23 as in effect on Feb. 1, 2004 from U.S. Pat. No. 8,374,887.
Felkey, Bill G., “Integrating Technology at the Point of Care”, Insight, Jan. 2004—pp. 8-10.
Formula for Patient Safety; ScriptPro; Aug. 17, 2003.
Fred Puckett, “Medication-management component of a point-of-care information system,” Am. J. Health-Syst.Pharm., Jun. 15, 1995, pp. 1305-1309, vol. 52, American Society of Health-System Pharmacists, Inc.
“GE ImageQuant TL 7.0 Image Analysis Software” User Manual , May 2007, http://nba.uth.tmc.edu/Assets/pdf/other/typhoon-supporting-files/IQTL-UserManual.pdf, Uppsala, Sweden.
Gerald E. Meyer et al., “Use of bar codes in inpatient drug distribution,” Am. J. Hosp. Pharm., May 1991, pp. 953-966, vol. 48, American Society of Hospital Pharmacists, Inc.
Ghent, Natale, “Pharmacists go digital to fight shortage”, Pharmacy Practice 20.11 (Nov. 2004): 47—2 pages.
Gilad J. Kuperman, M.D. et al., “Innovations and research review: The impact of the Help computer system on the LDS Hospital paper medical record,” Topics in Health Record Management, 1991, pp. 76-85, vol. 12, Issue 2, Aspen Publishers, Inc.
“Global Med Announces First Safetrace TX™ Sale,” Apr. 1, 1999, 2 pages.
Global Med Technologies, Inc. Introduces PeopleMed™.com, inc., A Chronic Disease Management Application Service Provider (ASP) Subsidiary, Jan. 11, 2000, 2 pages, Global med Technologies, Inc., Denver, CO.
Gretchen A. Barry et al., “Bar-code technology for documenting administration of large-volume intravenous solutions,” American Journal of Hospital Pharmacy, Feb. 1989, pp. 282-287, vol. 46, American Society of Hospital Pharmacists.
H. Paul Hammann et al., “A World Wide Web Accessible Multi-Species ECG Database,” 1997, pp. 7-12, ISA.
Halverson, Daniel R. IsoRx: TelePharmacy Software presentation—23 pages.
Henry J. Lowe et al., “WebReport: A World Wide Web Based Clinical Multimedia Reporting System,” 1996, pp. 314-318, Amia, Inc.
“Hospitals battle errors with bar codes,” Mar. 24, 2004, 3 pages, MSNBC.
Howard L. Bleich et al., “Clinical Computing in a Teaching Hospital,” Use and Impact of Computers in Clinical Medicine, 1987, pp. 205-223 and selected pages, Springer-Verlag, New York, NY.
http://isorx.com/ Jan. 29, 2004.
http://www.scriptpro.com/products//sp-200/main.htm, Feb. 13, 2004, Product listing for SP 200® Robotic Prescription Dispensing System.
http://www.scriptpro.com/products/space/space200.htm, Feb. 10, 2004, Product listing for SP Automation Center 200TM (Space 200TM) Prescription Dispensing Automation Center.
Hughes, Shirley, “Bedside Terminals: Clinicom,” Clinical Computing, Jan./Feb. 1988, pp. 22-28, vol. 5, No. 1.
IPR Decision Paper No. 8 Entered Aug. 13, 2015 from U.S. Pat. No. 8,374,887.
IPR Final Written Decision Paper No. 29 Entered Jul. 11, 2016 from U.S. Pat. No. 8,374,887.
James Kazmer et al., “The Creation of Virtual Electronic Medical Record,” 1996, 17 pages.
Jennifer Langham; “Taking Automation to New Levels,” Insight, the QS/1 Magazine, Oct. 2002; pp. 2-5.
John Frady; “What's New in RxCare Plus 17.2,” Insight, the QS/1 Magazine, Apr. 2002; pp. 2-3, 14.
Jones, et al., “Use of a remote computerized system for study documentation in clinical trials” Drug Information Journal, Oct.-Dec. 1998, vol. 32, No. 4 oe pp. 1153-1163.
Karen E. Bradshaw et al., “Physician decision-making—Evaluation of data used in a computerized ICU,” International Journal of Clinical Monitoring and Computing, 1984, pp. 81-91, vol. 1, Martinus Nijhoff Publishers, Netherlands.
Kastango, Eric S. and Bradshaw, Brian D., “USP chapter 797: Establishing a practice standard for compounding sterile preparations in pharmacy” Am J Health-Syst Pharm., Sep. 15, 2004, vol. 61—pp. 1928-1938.
Kenneth N. Barker et al., “Effect of an automated bedside dispensing machine on medication errors,” American Journal of Hospital Pharmacy, Jul. 1984, pp. 1352-1358, vol. 41, No. 7, American Society of Hospital Pharmacists.
Keeys, Christopher A. et al., “Providing nighttime pharmaceutical services through telepharmacy” Am J Health-Syst Pharm, Apr. 15, 2002, vol. 59—pp. 716-721.
Khan, Shamima et al., “Is There a Successful Business Case for Telepharmacy?” Telemedicine and e-Health, vol. 14, No. 3, Apr. 2008, pp. 235-245.
Kimber, Michael B. et al., “Telepharmacy-Enabling Technology to Provide Quality Pharmacy Services in Rural and Remote Communities” Journal of Pharmacy Practice and Research, vol. 36, No. 2, 2006—128-133.
Kodak DirectView PACS—Rural Hospital Joins the Big Leagues PACS/Enterprise Information management (EIM) Solution—www.kodak.com/go/medical—4 pages.
Kosub, David, “Device allows pharmacy care in remote areas” Pharmacy Practice, vol. 20, No. 10, Oct. 2004—pp. 12-13.
Koutnik, Eileen, Assistnat Editor, Pharmacy Times, “The Pharmacy of Tomorrow” Pharmacy Times, Aug. 1, 2003—3 pages.
Larry B. Grandia, B.S.E. et al., “Building a computer-based Patient Record System in an Evolving Integrated Health System,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 19-55, Computer-based Patient Record Institute, Inc., Bethesda, MD.
Lefkowitz, Sheldon et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System,” 1991, pp. 239-242, Hospital Pharmacy, vol. 26.
LP, “ATM-STyle Drug Dispensers Taking Hold In Areas With Limited Pharmacist Services” Pharmacy Practice News, Jan. 2004, vol. 31, No. 1—4 pages.
“The Longitudinal Clinical Record: A View of the Patient, taken from Proceedings of the 1994 Annual HIMSS Conference, Feb. 14, 1994, pp. 239-250, Healthcare Information and Management Systems Society, Chicago, Illinois, USA.”
Lustig, Ahuva, “Medication error prevention by pharmacists—An Israeli solution” Pharmacy World & Science, 2000, vol. 22, No. 1—pp. 21-25.
Medicaid Memo—Department of Medical Assistance Services (Converting NDCs from 10-digits to 11-digits) May 31, 2007.
Medcin® Technical Overview, undated, 111 pages, Medicomp Systems.
Michael H. Mackin, “Impact of Technology on Environmental Therapeutic Device Design,” Medical Instrumentation, Feb. 1987, pp. 33-35, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation.
Michelle M. Casey, M.S., Jill Klingner, R.N., M.S., and Ira Moscovice, Ph.D.; “Access to Rural Pharmacy Services In Minnesota, North Dakota, and South Dakota,” Working Paper Series, Jul. 2001, #36.
Monane et al., “Improving Prescribing Patterson for the Elderly Through an Online Drug Utilization Review Intervention”, JAMA, Oct. 14, 1998, vol. 280, No. 14—pp. 1249-1252.
Morris, Aisha M., Schneider, Philip J., Pedersen, Craig A. and Mirtallo, Jay M. “National survey of quality assurance activities for pharmacy-compounded sterile preparations” Am J Health-Syst Pharm, Dec. 15, 2003, vol. 60—pp. 2567-2576.
Murray, Michael D. et al. “Effects of Computer-based Prescribing on Pharmacist Work Patterns” Journal of the American Medical Informatics Association, Nov./Dec. 1998, vol. 5, No. 6—pp. 546-553.
Napoli, M. et al., “Picture archiving and communication in radiology”, Rays. Jan.-Mar. 2003—PubMed-NCBI http://www.ncbi.nlm.m=nih.gov/pubmed/14509181—Abstract.
Nissen et al., Can telepharmacy provide pharmacy services in the bush, School of Pharmacy, University of Queensland, Brisbane, Australia, Journal of Telemedicine and Telecare 2003, vol. 9 (Suppl. 2): S2:39-41.
North Dakota Century Code Statute Law—State Board of Pharmacy—219 pages.
Parks, Liz, “Annual report of retail pharmacy: Using central-fill to maximize dispensing” Drug Store News, Aug. 20, 2001 vol. 24, No. 11—pp. 51, 75.
Parsons, et al., “Digital Media—Can I Change a Graphic's File Size?”, New Perspectives on Computer Concepts—Course Technology, 2011, Cengage Learning, Boston, MA.
Paul H. Perlstein et al., “Computer-Assisted Newborn Intensive Care,” Pediatrics, Apr. 1976, pp. 494-501, vol. 57, No. 4, American Academy of Pediatrics, Inc., Evanston, Illinois.
Paul H. Perlstein et al., “Future Directions for Device Design and Infant Management,” Medical Instrumentation, Feb. 1987, pp. 36-41, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation.
PCA II Multi-Mode Cartridge Operator's Manual, Sep. 1995, approx. 40 pages, Baxter Healthcare Corporation, Deerfield, IL.
Pesce, James, “Bedside Terminals: Medtake,” Clinical Computing, Jan. /Feb. 1988, pp. 16-21, vol. 5, No. 1.
Peter Lord et al., MiniMed Technologies Programmable Implantable Infusion System, Annals New York Academy of Science, pp. 66-71, describing clinical trials from Nov. 1986.
Peterson et al., The North Dakota Telepharmacy Project Restoring and Retaining Pharmacy Services in Rural Communities—Presentation North Dakota State University, Fargo, North Dakota.
Petition for Inter Partes Review Baxter International Inc. v. Becton, Dickinson and Company for U.S. Pat. No. 8,374,887, pp. 1-69.
Pharmacy Automation Online Vendors Page; Internet Archive Wayback Machine; http://pharmacyautomation.com/vendors.html—3 pages.
Pharmacy Data Management (PDM) Technical Manual/Security Guide Version 1.0, Sep. 1997—55 pages.
Pharmacy education and practice out of sync? (Roundtable) Chain Drug Review, vol. 25, No. 6, Mar. 17, 2003, RX2 (6).
Prem S. Chopra, Virgil A. Thomason, and Dell M. Stinett; “Voice-Activated Networked Workstation for a Physically Disabled Physician,” 10-7803-2050-6/94 1994 IEEE, pp. 478-479.
Product literature, Baxter Healthcare Corporation, “Flo-Gard® 6201 Volumetric Infusion Pump,” 1992, 2 pages.
Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” 1988, 2 pages.
Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” undated, 2 pages.
Remote Dispensing Regulations, NABPLAW Sep. 2003.
Woodall, Sandra C., Remote Order Entry and Video Verification; Reducing After-Hours Medication Errors in a Rural Hospital; S. Woodall; Joint Commission on Accreditation of Healthcare Organizations; vol. 30; No. 8, Aug. 2004.
Rich Muller; “NRx QS/1's Premium Pharmacy Software,” Insight, the QS/1 Magazine, Jul. 2003; pp. 2-3, 12-15.
Rouse, et al., Academy of Managed Care Pharmacy et al., “White paper on pharmacy technicians 2002: Needed changes can no longer wait” Am J Health-Syst Pharm, Jan. 1, 2003, vol. 60—pp. 37-51.
Rule Section 291.36—Class A Pharmacies Compounding Sterile Pharmaceuticals—1 page.
Schrenker, Richard and Cooper, Todd, “Building the Foundation for Medical Device Plug-and-Play Interoperability”.
Seifert et al.; “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education 2004; 68 (3) Article 60. Jul. 16, 2004.
Standard Specification for Transferring Clinical Laboratory Data Messages Between Independent computer Systems, Annual Book of ASTM Standards, Mar. 25, 1988, pp. 1-16, E 1238-88, Global Engineering Documents, Philadelphia, PA.
Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Annual Book of ASTM Standards, Jun. Mar. 1994, pp. 132-210, E 1238-94, Philadelphia, PA.
Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Aug. 10, 1997, 79 pages, ASTM E 1238-97, West Conshohocken, PA, United States.
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Annual Book of ASTM Standards, Jun. 1991, 15 pages, E 1394-91, Philadelphia, PA.
Suzanne Carter, RN, Ed.D. et al., “The Computer-based Patient Record: The Jacobi Medical Center Experience,” Second Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1996, pp. 71-95, Computer-based Patient Record Institute, Inc., Bethesda, MD.
T. Allan Pryor et al., “help—A Total Hospital Information System,” Proceedings of the Fourth Annual Symposium on Computer Applications in Medical Care, Nov. 2-5, 1980, pp. 3-7, vol. 1, Institute for Electrical and Electronics Engineers, New York, NY.
T.E. Bozeman et al., “The Development and Implementation of a Computer-Based Patient Record in a Rural Integrated Health System,” Third Annual Nicholas E. David Award Proceedings of the CPR Recognition Symposium, 1997, pp. 101-130, Computer-based Patient Record Institute, Inc., Bethesda, MD.
“Telepharmacy project expands students' practice experience” Telemedicine Report, vol. 6, No. 1, Jan. 2004 oe 4 pages.
The World's First Fully Integrated Workflow Manager for I.V. Rooms, IntelliFlowRx Brochure, For Health Technologies Inc,. United States, May 2008.
Title 22. Examining Boards, 22 TAC Section 1.161; texinfo.library.unt.edu/Texasregister/html/2001/sep-14/PROPOSED/22.EXAMING BOARDS.html—Sep. 20, 2014, pp. 1-70.
Ukens, Carol, “Pharmacist shortage boosts telepharmacy” Drug Topoics, Jun. 3, 2002; 146, 11—p. 53.
Valeriy Nenov et al., “Remote Analysis of Physiological Data from Neurosurgical ICU Patients,” Journal of the American Medical Informatics Association, Sep./Oct. 1996, pp. 318-327, vol. 3, No. 5.
“Victor J. Perini et al., Comparison of automated medication-management systems,: Am. J. Hosp. Pharm., Aug. 1, 1994, pp. 1883-1891, vol. 51, American Society of Hospital Pharmacists, Inc.”.
Vincenzo Della Mae et al., “HTML generation and semantic markup for telepathology,” Computer Networks and ISDN Systems, 1996, pp. 1085-1094, vol. 28, Elsevier Science B.V.
Website information for Cartharsis Medical Technology Products, Dec. 9, 2001, 15 pages.
Website information for MedPoint™, Mar. 13, 2003, 20 pages, Bridge Medical, Solana Beach, CA.
William R. Dito et al., “Bar codes and the clinical laboratory: adaptation perspectives,” Clinical Laboratory Management Review, Jan./Feb. 1992, pp. 72-85, Clinical Laboratory Management Association, Inc.
Wills, Robert D., “Drug Images and Drug Imprints” Insight, Apr. 2001—p. 7.
Yvonne Mari Abdoo, “Designing a Patient Care Medication and Recording System that Uses Bar Code Technology,” Computers in Nursing, May/Jun. 1992, pp. 116-120, vol. 10, No. 3.
Jon Phillips, Telepharmacy at Texas Tech, PowerPoint, Jan. 26, 1997, https://web.archive.org/web/20040509162423/http:/www.ttuhsc.edu/telemedicine/Powerpoint/Telepharmacy%20presentation%2042503.ppt.
A.H. McMorris et al. “Are Process Control Rooms Obsolete?”, Control Engineering, pp. 42-47, Jul. 1971.
Standard Specification for Transferring Clinical Observations between Indepdendent Computer Systems, Annual Book of ASTM Standards, Nov. 14, 1991, pp. 1-64, ASTM E 1238-91,Philadelphia, PA.
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Dec. 10, 1997; 15 pages, ASTM E 1394-97, West Conshohocken, PA, United States.
Web site information, Information Data Management, Inc.'s PCMS: Plasma Center Management System, Dec. 14, 2001, 11 pages.
Web site Information, Wyndgate Technologies' SafeTrace Tx™, undated, 15 pages.
Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems, Mar. 11, 1991; 7 pages, ASTM E 1381-91, Philadelphia, PA, United States.
Atherton, H.D., Dollberg, S., Donnelly, M.M., Perlstein, P. H. Roath, S.B., “Computerized Temperature Control of the Low-Birth-Weight Infant: A 20-Year Retrospective and Future Prospects,” Biomedical Instrumentation and Technology, Jul./Aug. 1994, pp. 302-309, vol. 28 No. 4.
Friesdorf, W., Grob-Alltag, F., Konichezky, S., Schwilk, B., Fattroth, A., Fett, P., “Lessons learned while building an integrated ICU workstation,” International Journal of Clinical Monitoring and Computing, 1994, pp. 89-97, vol. 11.
Gammon, K., Robinson, K., “Bedside Data System Aids Pharmacy,” Computers in Healthcare, Dec. 1988, pp. 35-37, vol. 9 No. 12.
Graseby 3100 Syringe Pump, Graseby Medical Ltd., A Cambridge Electronic Industries Company, England, 2 pages.
Kampmann, J., Lau, G., Kropp, ST., Schwarzer, E., Hernandez Sande, C., “Connection of electronic medical devices in ICU according to the standard ‘MIB’,” International Journal of Clinical Monitoring and Computing, 1991, pp. 163-166, vol. 8.
Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999 (32 pages).
Carson, Ewart et al., “A Systems Methodology for the Development and Evaluation of a Telematic Home Haemodialysis Service,” Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997, Chicago, Illinois, pp. 907-910.
Communication pursuant to Article 94(3) EPC dated Jun. 12, 2019 in corresponding EP Application No. 18 000 180.2.
Anonymous: “Sceye document scanner for the professional desktop”, 2011, pp. 1-2, XP055590334, Retrieved from the Internet: URL: https://www.tradescanners.com/pdf/sceye-brochure.pdf.
Canadian Office Action/Notice of Requisition dated Dec. 27, 2018 mailed in corresponding Canadian Application No. 2,889,210.
Related Publications (1)
Number Date Country
20190035498 A1 Jan 2019 US
Provisional Applications (1)
Number Date Country
61719235 Oct 2012 US
Continuations (2)
Number Date Country
Parent 15339390 Oct 2016 US
Child 16146437 US
Parent 14438544 US
Child 15339390 US